Malignant melanoma, excluding all cancers (controls excluding all cancers)

C3_MELANOMA_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — C51.03&, C51.13&, C51.23&, C51.82&, C52.93&, C69.02&, C69.82&, C69.92&, D03.9& Hospital discharge: ICD-10 — C51.03&, C51.13&, C51.23&, C51.82&, C52.93&, C69.02&, C69.82&, C69.92&, D03.9& Cause of death: ICD-10 — C51.03&, C51.13&, C51.23&, C51.82&, C52.93&, C69.02&, C69.82&, C69.92&, D03.9& Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 877[0-4] Cancer registry: Behaviour codes — 3 4 out of 7 registries used, show all original rules.	183
4. Check minimum number of events None	183
5. Include endpoints C3_MELANOMA_SKIN_EXALLC CD2_UVEAMELANOMA CD2_INSITU_MELANOMA	7094
6. Filter based on genotype QC (FinnGen only)	7094

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_MELANOMA_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_MELANOMA_SKIN_EXALLC\|CD2_UVEAMELANOMA\|CD2_INSITU_MELANOMA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	C6902\|D039\|C5103\|C5113\|C5123\|C5182\|C5293\|C6982\|C6992
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C6902\|D039\|C5103\|C5113\|C5123\|C5182\|C5293\|C6982\|C6992
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C6902\|D039\|C5103\|C5113\|C5123\|C5182\|C5293\|C6982\|C6992
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	877[0-4]
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant melanoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7094	3446	3648
Unadjusted period prevalence (%)	1.40	1.17	1.61
Median age at first event (years)	63.89	60.35	67.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5265: Matched controls
52650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

341

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

323.0

411

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

323.0

320

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

411

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

160.4

323.0

345

H02AB02

ATC

dexamethasone; systemic

28.9

323.0

525

201

ZZR00

NOMESCO Finland

Flap of skin

57.3

323.0

442

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

162.5

323.0

592

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

1305.2

323.0

365

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

323.0

649

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

24.4

323.0

1371

749

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

323.0

644

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

323.0

902

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

32.4

323.0

2082

1040

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

323.0

361

R23.8

ICD-10 Finland

Other and unspecified skin changes

5.1

323.0

1485

3744

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

323.0

1012

PJA12

NOMESCO Finland

Sentinel node biopsy

2084.9

323.0

1699

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

36.5

323.0

863

281

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

+∞

323.0

311

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

736

L57.0

ICD-10 Finland

Actinic keratosis

6.5

323.0

1090

2022

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

323.0

364

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

3276.6

323.0

319

D03.5

ICD-10 Finland

Melanoma in situ of trunk

4051.3

323.0

387

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

323.0

445

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

14.1

323.0

821

682

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

472

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

14.3

323.0

1035

883

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

323.0

528

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

11.5

323.0

903

929

JN4BD

NOMESCO Finland

Extensive body CT

7.9

323.0

835

1229

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

323.0

942

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

30.1

323.0

982

398

C61

ICD-10 Finland

Malignant neoplasm of prostate

261.8

323.0

433

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

323.0

315

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

9.5

323.0

1347

1844

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

624.1

323.0

351

C43

ICD-10 Finland

Malignant melanoma of skin

1659.8

316.5

305

S77

ICPC

Malignant neoplasm of skin

283.3

315.0

319

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

314.7

299

S18

ICPC

Laceration/cut

3.1

314.7

2894

15024

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

165.3

310.9

326

WF049

NOMESCO Finland

Radiotherapy of metastasis

1619.6

310.1

299

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

2997.1

307.0

294

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

302.0

287

115

Kela drug reimbursment

Breast cancer

+∞

278.6

265

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

275.4

262

180

Kela drug reimbursment

Interferon alfa

+∞

269.0

256

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

263.7

251

A04AA02

ATC

granisetron; systemic, transdermal

274.8

257.0

261

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

253.1

241

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

251.0

239

116

Kela drug reimbursment

Prostate cancer

+∞

230.9

220

SPAT1153

SPAT

Removal of sutures

2.7

223.7

2174

10892

WF002

NOMESCO Finland

Radical radiotherapy

110.7

223.2

243

TQW99

NOMESCO Finland

Other minor procedure on skin

7.9

217.7

528

732

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

17.9

212.3

340

202

JN4AD

NOMESCO Finland

Body CT examination

7.5

208.4

523

762

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

+∞

207.6

198

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

+∞

206.6

197

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

12.9

203.3

374

311

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

514.4

201.0

199

S82

ICPC

Naevus/mole

3.7

196.8

993

3121

WF003

NOMESCO Finland

Adjuvant radiotherapy

334.0

193.8

195

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

189.7

181

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

2009.9

189.6

183

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

188.6

180

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1996.6

188.5

182

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

196.9

183.2

190

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1916.8

182.2

176

ZZA00

NOMESCO Finland

Split skin graft

9.1

181.6

401

473

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

177.0

169

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

13.5

176.3

316

247

D22

ICD-10 Finland

Melanocytic naevi

7.2

172.9

443

660

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

170.7

163

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.6

169.3

1650

7974

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

168.6

161

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

197.4

165.9

172

XX3DW

NOMESCO Finland

Time consuming IT work

5.4

164.5

534

1080

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

163.3

156

Z51.5

ICD-10 Finland

Palliative care

8.7

162.9

369

453

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

162.3

155

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

162.3

155

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

807.1

160.4

157

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

159.1

1564

7545

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

19.3

158.4

246

133

A03FA01

ATC

metoclopramide; systemic, rectal

3.2

157.6

935

3279

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

326.5

155.7

157

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

154.9

148

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

70.3

153.8

177

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

1568.7

153.8

149

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

152.8

146

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

152.8

146

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

9.9

152.1

318

339

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

142.3

136

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

142.3

136

JN4CD

NOMESCO Finland

Very extensive body CT

10.0

142.1

296

313

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

140.2

134

L82

ICD-10 Finland

Seborrhoeic keratosis

2.7

135.3

1078

4547

L03AB05

ATC

interferon alfa-2b; parenteral

75.6

135.2

154

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

133.9

128

ZX090

NOMESCO Finland

Other technic of radiotherapy

232.5

132.5

136

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

+∞

130.7

125

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

130.2

2067

12289

HAC20

NOMESCO Finland

Total mastectomy

174.4

130.0

136

L02BG04

ATC

letrozole; oral

22.1

128.2

190

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

127.8

127.7

137

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

126.5

121

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1247.1

125.5

122

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

29.4

125.3

171

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

216.7

123.2

127

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

119.2

114

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

116.7

2446

16052

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

33.5

115.9

153

ZXC50

NOMESCO Finland

Cryotherapy

7.3

114.3

287

411

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

382.0

112.8

113

HAB40

NOMESCO Finland

Wedge excision of mammary gland

26.0

112.7

159

L03AA13

ATC

pegfilgrastim; parenteral

564.7

112.3

111

L01XE23

ATC

[U] dabrafenib; oral

+∞

111.8

107

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

+∞

111.8

107

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

17.2

111.5

180

108

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

149.5

110.6

117

L02AE02

ATC

leuprorelin; implant, parenteral

19.0

109.8

171

ZX070

NOMESCO Finland

Intensity modified radiotherapy

368.0

108.7

109

L01BC06

ATC

capecitabine; oral

+∞

108.7

104

A04AA01

ATC

ondansetron; systemic, rectal

7.3

108.4

272

389

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

107.6

103

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

9.3

106.8

230

257

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1059.2

106.7

104

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

106.6

102

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

105.5

101

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.7

105.3

381

856

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

104.5

100

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

11.1

103.9

203

189

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

21.5

103.9

155

L02BB03

ATC

bicalutamide; oral

1028.0

103.6

101

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1017.6

102.5

100

XQ845

NOMESCO Finland

Dermatoscopy

13.4

101.9

182

140

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

+∞

101.3

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

101.3

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.6

101.3

272

428

HA1AA

NOMESCO Finland

X-ray mammography

5.9

99.6

295

527

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

9.5

99.4

211

230

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

+∞

99.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

99.1

1064

5172

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

98.2

L01AX03

ATC

temozolomide; systemic

+∞

98.2

L02BA01

ATC

tamoxifen; oral

79.6

96.5

109

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

96.1

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

96.1

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

96.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

95.8

2095

13633

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

944.9

95.2

WZC30

NOMESCO Finland

Teaching

2.8

92.7

658

2536

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

126.0

92.3

C50.99

ICD-10 Finland

Breast, unspecified

+∞

91.9

Y77

ICPC

Malignant neoplasm prostate

162.8

91.4

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

162.8

91.4

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

903.5

91.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

893.1

90.0

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

89.8

Z2221

NOMESCO Finland

Medical doctor

2.0

89.3

1517

8934

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

187.1

88.5

XCD10

NOMESCO Finland

Electrophysiological examination of eye

5.3

87.5

280

548

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

+∞

85.6

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

83.5

ZX080

NOMESCO Finland

Image guided radiotherapy

285.9

82.8

A04AA55

ATC

palonosetron, combinations; systemic

+∞

82.5

L01XE25

ATC

[U] trametinib; oral

+∞

82.5

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

+∞

81.4

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

126.3

81.1

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

29.0

79.2

108

XQ848

NOMESCO Finland

Dermatological photography

6.1

79.0

225

382

WX402

NOMESCO Finland

General anaesthesia

2.4

78.9

754

3416

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

65.3

77.7

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

+∞

76.2

C69.3

ICD-10 Finland

Malignant neoplasm: Choroid

+∞

76.2

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

260.8

75.6

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

6.7

75.1

199

307

DAB10

NOMESCO Finland

Partial excision of auricle

377.6

74.9

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

6.3

73.9

206

340

NK6AN

NOMESCO Finland

Total body bone isotope imaging

28.6

73.8

101

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

192.6

73.3

C50

ICD-10 Finland

Malignant neoplasm of breast

190.1

72.3

9734

FHL

Excision and local plastic or associated free skin grafting

14.0

72.3

126

L03AA02

ATC

filgrastim; parenteral

46.5

71.0

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

71.0

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

356.9

70.8

WX110

NOMESCO Finland

Local anesthesy

1.7

70.2

3228

25511

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

69.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

147.9

69.1

ZZA50

NOMESCO Finland

Full thickness skin graft

38.4

68.3

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

44.8

68.1

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

41.1

67.7

PJA10

NOMESCO Finland

Exploration of lymph nodes

18.8

67.6

105

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

666.4

67.1

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

66.8

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

31.2

66.6

ZXE00

NOMESCO Finland

One hour or less

1.7

65.8

1972

13711

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

65.7

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

65.7

8720/3-C69.3

ICD-O-3

Malignant melanoma, NOS, of choroid

+∞

64.7

JN6AD

NOMESCO Finland

CT of torso and neck

16.6

64.0

104

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.9

62.7

213

445

D06BB10

ATC

imiquimod; topical

3.8

62.3

284

787

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

62.3

483

1941

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

62.1

727

3601

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

61.6

ZXA00

NOMESCO Finland

Right side

1.7

60.8

1490

9694

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

9.3

60.8

129

141

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

18.7

60.6

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

12.4

60.6

111

B01AB05

ATC

enoxaparin; parenteral

1.8

60.4

1461

9465

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

49.3

60.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

594.6

59.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

594.6

59.8

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

59.7

213

469

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

14.9

59.7

101

8720/3-C69.9

ICD-O-3

Malignant melanoma, NOS, of eye, NOS

+∞

59.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

59.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

59.5

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

59.5

C43.74

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip acral

+∞

59.5

S29

ICPC

Skin symptom/complaint other

2.0

59.2

899

4955

N02AA05

ATC

oxycodone; systemic

2.2

59.1

676

3306

J01DB01

ATC

cefalexin; oral

1.7

58.9

4021

34494

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.6

58.3

214

485

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

15.2

57.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

57.4

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

+∞

57.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

57.4

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

+∞

57.4

R4110

NOMESCO Finland

Physiotherapy

1.8

57.3

1301

8236

S26

ICPC

Fear of cancer of skin

9.6

56.6

118

125

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

56.3

8720/3-C44.2

ICD-O-3

Malignant melanoma, NOS, of external ear

+∞

56.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

55.3

N02BE01

ATC

paracetamol; systemic, rectal

1.8

55.0

4334

38231

A04AD12

ATC

aprepitant; systemic

543.4

54.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

54.4

448

1856

C69.39

ICD-10 Finland

Malignant tumor in chorioidea other or unspecified histology

+∞

54.2

A79

ICPC

Malignancy NOS

77.2

54.0

ZXA05

NOMESCO Finland

Left side

1.7

53.9

1384

9067

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.1

53.4

176

356

DAB00

NOMESCO Finland

Excision of lesion of auricle

13.5

53.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

53.2

L01EC02

ATC

dabrafenib; oral

+∞

53.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

53.2

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

52.2

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

52.2

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

+∞

52.2

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

113.1

51.8

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

37.1

51.6

WX002

NOMESCO Finland

Sedation and analgesia

1.8

51.6

1061

6477

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

263.0

51.2

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

51.1

TQB05

NOMESCO Finland

Puncture of skin of trunk

25.1

51.1

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

50.1

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

174.9

49.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

54.2

49.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.0

49.6

126

184

ZXC15

NOMESCO Finland

Use of photodynamic technique

9.7

49.3

102

107

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

49.0

C43.20

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal without histology

+∞

49.0

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

7.0

49.0

124

180

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

48.8

388

1575

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.3

48.1

153

298

I78.1

ICD-10 Finland

Naevus, non-neoplastic

4.5

48.0

178

408

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

105.0

47.8

Z3231

NOMESCO Finland

Registered nurse

1.7

47.6

1331

8879

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

15.1

47.2

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

4.4

47.0

177

412

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

3.0

46.7

290

1012

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

46.6

349

1368

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

13.2

46.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

45.9

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

45.9

L01EE01

ATC

trametinib; oral

+∞

45.9

S21

ICPC

Skin texture symptom/complaint

2.0

45.4

659

3538

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

44.8

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

+∞

44.8

C43.43

ICD-10 Finland

Malignant melanoma of the scalp and neck nodular

+∞

44.8

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

5.2

43.8

140

274

17281

ICD-8 Finland

Malignant melanoma of skin, Lower limb

+∞

43.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

43.8

X76

ICPC

Malignant neoplasm breast female

118.5

43.8

ZXC20

NOMESCO Finland

Use of chemical agents

5.8

43.7

127

222

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.9

43.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

29.3

43.0

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

221.7

42.9

C44

ICD-10 Finland

Other malignant neoplasms of skin

151.2

42.8

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

116.0

42.8

3016

Kela drug reimbursment

Binimetinib and encorafenib

+∞

42.8

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

42.8

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

42.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

42.8

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

42.8

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

56.0

42.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

420.8

42.2

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

16.4

42.0

1513

Kela drug reimbursment

Binimetinib and encorafenib

+∞

41.7

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

4.9

41.6

142

299

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

23.8

41.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

11.3

41.0

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

211.5

40.9

C43.4

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of scalp and neck

+∞

40.7

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

40.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

40.7

WX140

NOMESCO Finland

Parabulbar anesthesy

2.6

40.1

308

1223

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

108.3

39.7

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

108.3

39.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

17.9

39.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

39.6

D03.30

ICD-10 Finland

Melanoma in situ on the lip

+∞

39.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.8

39.5

172

459

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

47.4

38.8

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

4.9

38.7

131

274

C43.41

ICD-10 Finland

Malignant melanoma of the scalp and neck originating in lentigo maligna

+∞

38.6

8721/3-C44.9

ICD-O-3

Nodular melanoma of skin, NOS

+∞

38.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

63.3

38.1

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

72.4

37.9

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

5.5

37.7

115

214

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

37.7

353

1558

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

37.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

37.5

C43.3

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of other and unspecified parts of face

+∞

37.5

C69.02

ICD-10 Finland

Malignant tumor in conjunctival melanoma

+∞

37.5

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

37.5

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

369.8

37.0

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

15.0

36.5

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

36.5

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

36.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

36.5

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

15.5

36.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

36.4

725

4330

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

11.3

36.3

DHB00

NOMESCO Finland

Excision of lesion of external nose

14.7

36.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

359.6

36.0

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

35.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

35.4

B01AB10

ATC

tinzaparin; parenteral

2.6

35.2

266

1047

Z31.5

ICD-10 Finland

Genetic counselling

3.4

35.1

174

517

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

34.9

499

2653

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

95.7

34.7

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

34.4

207

708

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

12.0

34.3

L02BG06

ATC

exemestane; oral

339.2

33.9

Z3226

NOMESCO Finland

Physiotherapist

1.7

33.8

860

5514

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

33.8

1441

10512

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

120.8

33.7

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

12.6

33.4

17261

ICD-8 Finland

Malignant melanoma of skin, Trunk, except scrotum

+∞

33.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

33.4

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

33.4

L02BG03

ATC

anastrozole; oral

38.5

33.4

XKD00

NOMESCO Finland

Uroflowmetry

1.7

33.3

766

4769

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.4

33.1

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

171.0

32.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

171.0

32.7

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

4.0

32.6

134

341

ZX050

NOMESCO Finland

Stereotactic radiotherapy

30.9

32.5

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

+∞

32.3

D03.2

ICD-10 Finland

Melanoma in situ of ear and external auricular canal

+∞

32.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

32.3

8742/3-C44.3

ICD-O-3

Lentigo maligna melanoma of skin of other and unspecified parts of face

+∞

32.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

32.3

9733

FHL

Excision of skin change in operating room or anesthesia

4.5

31.8

115

259

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

24.6

31.3

1725D

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MUU TAI TARK MÄÄR]

+∞

31.3

WW500

NOMESCO Finland

Blood transfusion

3.6

31.0

142

397

ZZS00

NOMESCO Finland

Rotation flap

70.3

30.9

L03AB04

ATC

interferon alfa-2a; parenteral

23.3

30.9

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

314.6

30.8

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

30.8

658

4002

C90.0

ICD-10 Finland

Multiple myeloma

160.9

30.7

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

16.5

30.6

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

30.2

8721/3-C44.5

ICD-O-3

Nodular melanoma of skin of trunk

+∞

30.2

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

304.0

29.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

83.1

29.7

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

29.7

613

3687

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

45.2

29.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.6

29.4

103

225

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

66.3

28.9

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

293.4

28.8

Z51.0

ICD-10 Finland

Radiotherapy session

150.8

28.7

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

150.8

28.7

C43.22

ICD-10 Finland

Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type

+∞

28.1

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

7.2

27.7

A02BC02

ATC

pantoprazole; systemic

1.4

27.7

3024

26021

ZXC96

NOMESCO Finland

Robot assisted procedure

7.6

27.7

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

145.7

27.6

ZX120

NOMESCO Finland

Intravenous

2.0

27.5

355

1808

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

27.4

121

329

E0000UV

ATC

1.4

27.3

1706

13312

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

+∞

27.1

D03.8

ICD-10 Finland

Melanoma in situ of other sites

+∞

27.1

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

27.1

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

7.4

26.8

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

97.2

26.6

128

Kela drug reimbursment

Cancers of female genital organs

140.7

26.6

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

11.8

26.6

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.8

26.3

170

611

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

26.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

26.1

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

26.1

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

26.1

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

26.1

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

60.3

26.0

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.0

25.8

170

D06BX02

ATC

ingenol mebutate; topical

4.6

25.8

201

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

25.8

534

3207

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.0

25.6

151

511

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

135.6

25.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.5

25.3

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

5.8

25.3

125

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

25.2

545

3315

S79

ICPC

Neoplasm skin benign/unspecified

3.6

25.0

117

334

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

25.0

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

25.0

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

25.0

1906B

ICD-9 Finland

Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]

+∞

25.0

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

18.2

24.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.1

24.4

292

1443

ZX112

NOMESCO Finland

Subcutaneous

6.5

24.1

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.2

24.0

221

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

24.0

L02BX02

ATC

degarelix; parenteral

+∞

24.0

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

24.0

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

24.0

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

24.0

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

24.0

C43.64

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder acrally

+∞

24.0

17271

ICD-8 Finland

Malignant melanoma of skin, Upper limb

+∞

24.0

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

7.4

23.8

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

14.4

23.8

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

87.1

23.7

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

125.5

23.6

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.2

23.5

245

1138

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

18.5

23.0

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

22.1

23.0

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

22.9

C43.91

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin originating in lentigo maligna

+∞

22.9

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

22.9

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

22.9

K62.7

ICD-10 Finland

Radiation proctitis

+∞

22.9

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

22.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

22.9

A98

ICPC

Health maint/preventive medicine

1.6

22.8

4734

44744

L91.0

ICD-10 Finland

Hypertrophic scar

5.3

22.7

134

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

22.7

147

530

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

230.8

22.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

22.6

218

975

F16

ICPC

Eyelid symptom/complaint

2.2

22.6

231

1063

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

9.5

22.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

22.4

4181

38545

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

22.4

237

1108

5702

FHL

Local lymph node removal (eg armpit, groin)

45.2

22.3

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.2

22.2

209

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

21.4

22.1

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.8

21.9

142

511

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

21.9

D03.1

ICD-10 Finland

Melanoma in situ of eyelid, including canthus

+∞

21.9

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

21.9

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

21.9

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

21.9

C43.80

ICD-10 Finland

Overall malignant melanoma of the skin without histology

+∞

21.9

1725A

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MELAN EX LENTIGOMAL]

+∞

21.9

8742/3-C44.5

ICD-O-3

Lentigo maligna melanoma of skin of trunk

+∞

21.9

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

62.7

21.8

QBA10

NOMESCO Finland

Incision of skin of trunk

5.3

21.8

128

S08

ICPC

Skin colour change

2.1

21.8

243

1164

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

8.6

21.8

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

17.1

21.7

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

9.2

21.7

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

38.8

21.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.7

21.7

258

TQW40

SPAT

2.6

21.3

164

655

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

50.2

21.1

TQD05

NOMESCO Finland

Puncture of skin of lower limb

50.2

21.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

21.0

115

371

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

21.0

869

6199

S15

ICPC

Foreign body in skin

2.0

21.0

288

1502

L01CA04

ATC

vinorelbine; systemic

+∞

20.8

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

20.8

C69.00

ICD-10 Finland

Malignant tumor of the conjunctiva without histology

+∞

20.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

20.8

1CD02

NOMESCO Finland

+∞

20.8

C43.92

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type

+∞

20.8

L02BB04

ATC

enzalutamide; oral

+∞

20.8

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

20.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

20.8

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

20.8

UKC02

NOMESCO Finland

Cystoscopy

1.5

20.8

718

4924

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

21.5

20.8

8720/2-C44.5

ICD-O-3

Melanoma in situ of skin of trunk

210.7

20.6

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

110.4

20.6

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

22.4

20.3

A06AH03

ATC

naloxegol; oral

8.8

20.3

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

20.2

307

1664

D18.0

ICD-10 Finland

Haemangioma, any site

3.1

20.1

110

356

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

20.0

139

521

WX320

NOMESCO Finland

Spinalanesthesy

1.4

20.0

1047

7825

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.1

20.0

192

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.8

19.9

131

477

CH2S4

NOMESCO Finland

Photography of iris

57.7

19.9

QB5S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in back

57.7

19.9

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

19.8

L01EC03

ATC

encorafenib; oral

+∞

19.8

1725B

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,SUPERFICIAL SPREAD]

+∞

19.8

1727B

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,SUPERFICIAL SPREAD]

+∞

19.8

L01XE15

ATC

[U] vemurafenib; oral

+∞

19.8

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

+∞

19.8

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

8.3

19.6

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

10.1

18.8

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

18.8

3770

FHL

Placing a radiating plate on the surface of the eye with additional measures

+∞

18.8

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

18.8

L01EE03

ATC

binimetinib; oral

+∞

18.8

C69.42

ICD-10 Finland

Malignant tumor of ciliary melanoma

+∞

18.8

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

18.6

200

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

38.5

18.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

18.5

971

7244

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.4

18.5

154

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.1

18.4

173

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

18.4

407

2488

CF2S4

NOMESCO Finland

Photography of conjunctiva

15.1

18.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

18.2

146

595

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

18.2

120

439

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.0

18.0

107

367

QDE00

NOMESCO Finland

Excision of loose skin or fold of skin from lower limb

33.0

17.9

C43.09

ICD-10 Finland

Malignant melanoma of the lip other or unspecified histology

+∞

17.7

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

17.7

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

17.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

17.7

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

17.7

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

17.7

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

66.8

17.7

R4120

NOMESCO Finland

Occupational therapy

1.8

17.6

286

1585

WF001

NOMESCO Finland

Preoperative radiotherapy

180.5

17.5

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

15.6

17.4

SPAT1211

SPAT

Application of soft bandage

1.7

17.4

392

2409

WF099

NOMESCO Finland

Other radiotherapy

13.9

17.2

S04

ICPC

Lump/swelling localized

1.7

17.2

367

2218

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

17.1

410

2564

R50.9

ICD-10 Finland

Fever, unspecified

1.6

17.0

517

3434

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

10.7

16.9

TQW20

NOMESCO Finland

Tatoe

19.3

16.8

L03AA04

ATC

21.9

16.8

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

16.7

1725C

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,NODULARE]

+∞

16.7

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

16.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

16.7

C43.2

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of ear and external auricular canal

+∞

16.7

C43.23

ICD-10 Finland

Malignant melanoma of the outer ear and in the outer ear canal nodular

+∞

16.7

8721/3-C44.7

ICD-O-3

Nodular melanoma of skin of lower limb and hip

+∞

16.7

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

16.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

16.7

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

16.7

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

16.7

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.2

16.6

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

5.2

16.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.4

1887

15872

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

7.9

16.0

G04BE03

ATC

sildenafil; oral

6.7

16.0

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.9

15.9

108

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

10.8

15.9

8000/3-C69.3

ICD-O-3

Neoplasm, malignant of choroid

+∞

15.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

15.6

C43.19

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye or other unspecified histology

+∞

15.6

1727D

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MUU TAI TARK MÄÄR]

+∞

15.6

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

15.6

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

15.6

L01XE41

ATC

[U] binimetinib; oral

+∞

15.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

15.6

L01XE46

ATC

[U] encorafenib; oral

+∞

15.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

15.6

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

15.6

3779

FHL

Other operations in this group include disc removal

+∞

15.6

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

15.6

8744/3-C44.9

ICD-O-3

Acral melanoma of skin, NOS

+∞

15.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

15.6

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

15.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

15.6

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

85.3

15.6

XX1XN

NOMESCO Finland

Other isotope examination

85.3

15.6

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.8

15.5

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

160.4

15.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

15.0

231

1259

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

15.0

263

1499

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.8

14.9

103

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

5.4

14.9

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

14.8

416

2711

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.4

14.6

C43.21

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal originating in lentigo maligna

+∞

14.6

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

14.6

C69.99

ICD-10 Finland

Malignant tumor in unspecified localization in eye or other unspecified histology

+∞

14.6

C43.12

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type

+∞

14.6

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

14.6

L02BX03

ATC

abiraterone; oral

+∞

14.6

C69.45

ICD-10 Finland

Melanoma of iris

+∞

14.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

14.6

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

14.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

14.6

D03.0

ICD-10 Finland

Melanoma in situ of lip

+∞

14.6

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

14.6

-54

ICPC

Repair/fix-suture/cast/prosth device

2.4

14.6

120

500

153

Kela drug reimbursment

Lenalidomid

80.3

14.6

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

3.9

14.5

153

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

150.3

14.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

150.3

14.5

D03

ICD-10 Finland

Melanoma in situ

150.3

14.5

ZZS10

NOMESCO Finland

Transposition flap

150.3

14.5

L04AX04

ATC

lenalidomide; oral

150.3

14.5

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.1

14.2

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.1

14.2

155

740

QDE20

NOMESCO Finland

Excision and repair of scar or web of skin of lower limb

9.1

14.2

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

53.4

13.8

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

53.4

13.8

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

13.8

190

997

ELB50

NOMESCO Finland

Total parotidectomy

11.4

13.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

13.6

111

462

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

13.5

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

13.5

C43.11

ICD-10 Finland

Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna

+∞

13.5

C43.93

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin nodular

+∞

13.5

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

13.5

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

13.5

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

13.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

13.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.5

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

+∞

13.5

C51.13

ICD-10 Finland

Melanoma and labium minus

+∞

13.5

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

13.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

13.5

D75

ICPC

Malignant neoplasm colon/rectum

34.1

13.5

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

8.3

13.5

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

10.9

13.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

140.3

13.4

ZXB10

NOMESCO Finland

Medial

5.4

13.4

S97

ICPC

Chronic ulcer skin

1.7

13.3

255

1495

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.3

1672

14126

TQC05

NOMESCO Finland

Puncture of skin of upper limb

13.8

13.2

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

40.1

13.1

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

9.3

12.9

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

3.0

12.9

249

B01AB04

ATC

dalteparin; parenteral

1.9

12.9

193

1045

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.2

12.9

207

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

14.0

12.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.7

610

4455

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

7.5

12.6

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

12.6

362

CDC00

NOMESCO Finland

Enucleation of eye

70.0

12.6

R23

ICD-10 Finland

Other skin changes

3.7

12.5

148

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

12.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

12.5

1726B

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,SUPERFICIAL SPREAD]

+∞

12.5

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

12.5

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

12.5

8721/3-C44.6

ICD-O-3

Nodular melanoma of skin of upper limb and shoulder

+∞

12.5

8743/3-C44.4

ICD-O-3

Low cumulative sun damage melanoma of skin of scalp and neck

+∞

12.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

12.5

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

12.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

12.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

12.5

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

12.5

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

12.5

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

12.5

121

550

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.1

12.3

116

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.9

12.3

126

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

37.6

12.2

J01MA12

ATC

levofloxacin; systemic

1.4

12.2

733

5565

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

6.4

12.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.4

12.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

12.0

403

2736

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

8.2

12.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

21.3

12.0

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

12.0

236

1394

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

8.7

12.0

QAE99

SPAT

5.0

11.9

-59

ICPC

Other therap proced/minor surg NEC

2.2

11.9

124

583

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.0

11.8

116

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.8

11.8

126

KAC10

NOMESCO Finland

Total nephrectomy with capsule

14.7

11.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

11.7

625

8116

Z42.2

ICD-10 Finland

Follow-up care involving plastic surgery of other parts of trunk

16.4

11.6

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

65.1

11.6

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

65.1

11.6

329

Kela drug reimbursment

Lenalidomide

65.1

11.6

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

11.6

1028

8273

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.2

11.5

100

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

11.5

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

11.5

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

11.5

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

11.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

11.5

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

11.5

3054

Kela drug reimbursment

+∞

11.5

1523

Kela drug reimbursment

+∞

11.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

11.5

C43.54

ICD-10 Finland

Malignant melanoma of the torso acral

+∞

11.5

1726D

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MUU TAI TARK MÄÄR]

+∞

11.5

1XC18

NOMESCO Finland

+∞

11.5

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

11.5

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

11.5

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

11.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

120.2

11.4

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

120.2

11.4

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

120.2

11.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

11.4

2012

17592

L02AE04

ATC

triptorelin; parenteral

25.0

11.1

JFF23

NOMESCO Finland

Transversostomy

6.8

11.1

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.6

11.1

138

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

11.1

301

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

11.0

327

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.1

10.9

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

5.3

10.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

10.8

213

1259

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

6.1

10.7

QCE00

NOMESCO Finland

Excision of loose skin or fold of skin from upper limb

17.8

10.7

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

2.3

10.5

394

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.0

10.5

D01AE16

ATC

amorolfine; topical

1.4

10.5

496

3612

N05AX08

ATC

risperidone; systemic

0.6

10.5

140

2366

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

7.3

10.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

110.2

10.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

110.2

10.4

8720/2-C44.6

ICD-O-3

Melanoma in situ of skin of upper limb and shoulder

110.2

10.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

10.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

10.4

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

10.4

8743/3-C44.3

ICD-O-3

Low cumulative sun damage melanoma of skin of other and unspecified parts of face

+∞

10.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

10.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

10.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

10.4

C69.03

ICD-10 Finland

Malignant tumor of conjunctival carcinoma

+∞

10.4

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

10.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

10.4

1727C

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,NODULARE]

+∞

10.4

XX7GT

NOMESCO Finland

Selective internal radio therapy (SIRT) with Yttrium

+∞

10.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

10.4

1727A

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MELAN EX LENTIGOMAL]

+∞

10.4

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

10.4

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

12.0

10.3

R23.4

ICD-10 Finland

Changes in skin texture

3.4

10.3

147

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.0

10.3

200

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

10.6

10.3

HAE99

NOMESCO Finland

Other reconstruction of breast

10.6

10.3

JG1BG

NOMESCO Finland

MRI of rectum

18.8

10.2

R31

ICD-10 Finland

Unspecified haematuria

1.5

10.2

391

2727

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

7.1

10.2

ZZF00

NOMESCO Finland

Graft of adipose tissue

7.1

10.2

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

23.4

10.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

10.2

223

3376

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

10.2

1415

9801

FHL

Free skin graft

7.9

10.1

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

7.9

10.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

10.0

300

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.7

10.0

258

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

10.0

331

2240

KC1GB

NOMESCO Finland

Cystography with X-ray

8.4

10.0

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

10.0

357

2458

Z42.4

ICD-10 Finland

Follow-up care involving plastic surgery of lower extremity

9.1

10.0

HA1HA

NOMESCO Finland

Tomosynthesis mammography

14.6

10.0

A04AA03

ATC

tropisetron; systemic

40.1

10.0

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.7

9.9

115

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

9.9

121

608

QBE99

SPAT

4.7

9.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.9

289

1904

QBA00

NOMESCO Finland

Puncture of skin of trunk

7.6

9.9

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

4.0

9.9

D23

ICD-10 Finland

Other benign neoplasms of skin

2.5

9.9

297

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

16.7

9.9

JFB30

NOMESCO Finland

Right hemicolectomy

4.2

9.8

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

20.0

9.8

ZXA10

NOMESCO Finland

Bilateral

1.3

9.8

808

6425

L02AE03

ATC

goserelin; implant

5.4

9.8

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

9.8

120

605

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

9.7

148

808

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

9.7

291

1930

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

9.6

297

1980

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

9.6

666

5165

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

9.6

385

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

8.4

9.5

R60.0

ICD-10 Finland

Localized oedema

1.4

9.4

461

3373

C44.79

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including hip or other unspecified histology

100.2

9.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

100.2

9.4

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

100.2

9.4

8720/2-C44.7

ICD-O-3

Melanoma in situ of skin of lower limb and hip

100.2

9.4

XX1AD

NOMESCO Finland

Other CT-examination

30.0

9.4

CBA10

NOMESCO Finland

Biopsy of eyelid

3.5

9.4

121

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

17.5

9.4

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

17.5

9.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

9.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

9.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

9.4

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

9.4

C43.10

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye without histology

+∞

9.4

8742/3-C44.6

ICD-O-3

Lentigo maligna melanoma of skin of upper limb and shoulder

+∞

9.4

8720/3-C80.9

ICD-O-3

Malignant melanoma, NOS, of unknown primary site

+∞

9.4

C43.02

ICD-10 Finland

Malignant melanoma of lip: 'superficial spreading' type

+∞

9.4

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

9.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

9.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

9.4

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

9.4

8720/3-C44.1

ICD-O-3

Malignant melanoma, NOS, of eyelid

+∞

9.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

9.4

8720/3-C69.0

ICD-O-3

Malignant melanoma, NOS, of conjunctiva

+∞

9.4

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

9.4

8744/3-C44.7

ICD-O-3

Acral melanoma of skin of lower limb and hip

+∞

9.4

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

9.4

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

9.4

8720/3-C44.8

ICD-O-3

Malignant melanoma, NOS, of overlapping lesion of skin

+∞

9.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

9.4

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

9.4

C43.8

ICD-10 Finland

Malignant neoplasm: Overlapping malignant melanoma of skin

+∞

9.4

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

9.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.4

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

9.4

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

9.4

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.8

9.4

198

CD2S4

NOMESCO Finland

Photography of eye

4.6

9.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

9.3

1576

13643

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

8.7

9.3

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

9.5

9.2

N03AX16

ATC

pregabalin; oral

1.3

9.2

931

7602

ZZR30

NOMESCO Finland

Flap of muscle

6.0

9.2

KEB00

NOMESCO Finland

Biopsy of prostate

3.6

9.2

108

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

9.1

236

1510

ELB40

NOMESCO Finland

Partial parotidectomy

2.9

9.1

184

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.3

9.0

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

15.6

9.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

9.0

177

1050

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.7

9.0

215

D22.0

ICD-10 Finland

Melanocytic naevi of lip

7.0

9.0

G04CA02

ATC

tamsulosin; oral

1.3

9.0

1062

8833

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

24.0

8.9

TQX00

NOMESCO Finland

Needle biopsy of skin

24.0

8.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

8.9

815

9907

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

8.9

273

1821

Z00.0

ICD-10 Finland

General medical examination

1.3

8.9

748

5961

M05BX04

ATC

denosumab; parenteral

1.8

8.9

147

829

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

10.7

8.8

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

8.7

142

795

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.7

8.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

8.7

421

3078

7323

FHL

Electrosection of TU bladder wall change

50.0

8.7

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

8.6

163

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.0

8.6

109

557

M01AX05

ATC

glucosamine; oral

1.3

8.6

911

7473

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

8.6

339

2383

D31.4

ICD-10 Finland

Benign neoplasm: Ciliary body

11.6

8.6

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.3

8.5

126

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

27.5

8.5

R4190

NOMESCO Finland

Nutritional therapy

2.2

8.5

351

HA1SA

NOMESCO Finland

Expansion mammography

20.0

8.5

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

20.0

8.5

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

8.5

134

744

WX142

NOMESCO Finland

Sub-tenon anesthesy

4.1

8.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

8.4

344

QXA05

NOMESCO Finland

Skin division, unspecified location

6.0

8.4

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

90.2

8.4

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

8.4

120

644

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.7

8.4

J05AB11

ATC

valaciclovir; oral

1.4

8.4

467

3496

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

8.4

622

4869

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

12.8

8.4

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.0

8.4

150

J01CA04

ATC

amoxicillin; systemic

1.2

8.3

3541

33257

PJ003

NOMESCO Finland

Adjuvant radiotherapy of neck, clavicle and axilla

+∞

8.3

189

Kela drug reimbursment

Imatinib

+∞

8.3

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

8.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

8720/3-C51.9

ICD-O-3

Malignant melanoma, NOS, of vulva, NOS

+∞

8.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

8.3

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

8.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

8.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

8.3

WC325

NOMESCO Finland

Demanding therapy of local tumor recidive with biomodifiers

+∞

8.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

8.3

1XC07

NOMESCO Finland

+∞

8.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

8.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

8.3

C43.81

ICD-10 Finland

Overall malignant melanoma of the skin originating in lentigo maligna

+∞

8.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

8.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

8.3

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

+∞

8.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

8.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

8.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

8.3

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

8.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.3

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

8.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

8.3

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

8.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

8.3

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

8.3

C51.03

ICD-10 Finland

Melanoma and labium majus

+∞

8.3

C69.20

ICD-10 Finland

Retina

+∞

8.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

8.3

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.3

2880

26556

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

8.3

244

1612

SPAT1324

SPAT

Screening procedure

0.7

8.3

273

3829

UJF32

NOMESCO Finland

Coloscopy

1.2

8.3

1018

8498

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

8.2

165

988

D31.0

ICD-10 Finland

Benign neoplasm: Conjunctiva

3.5

8.2

103

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

8.2

463

3474

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

8.2

204

1294

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.8

8.2

Z2446

NOMESCO Finland

Social worker

1.6

8.2

202

1277

N63

ICD-10 Finland

Unspecified lump in breast

1.7

8.2

148

857

XQ902

NOMESCO Finland

Other photography

4.3

8.1

CFC00

NOMESCO Finland

Excision of lesion of conjunctiva

4.3

8.1

S19

ICPC

Skin injury other

1.7

8.1

158

938

QCE20

NOMESCO Finland

Excision and repair of scar or web of skin of upper limb

8.1

N02AX02

ATC

tramadol; systemic, rectal

1.2

8.1

1771

15674

JG1CG

NOMESCO Finland

Extensive MRI of rectum

8.9

8.0

TKE10

NOMESCO Finland

Puncture of prostate

22.0

8.0

B07.9

ICD-10 Finland

Verruca simplex

1.9

7.9

108

569

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

4.0

7.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

7.9

382

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.2

7.9

123

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

7.9

765

9255

QB3S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in abdomen

13.0

7.9

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

7.7

7.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

7.8

693

5551

HA1BA

NOMESCO Finland

Extensive X-ray mammography

5.7

7.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.8

464

3516

PXA20

NOMESCO Finland

Extracorporal circulation of lower extremity using heart-lung assist device

45.0

7.7

QA9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head or neck, unspecified

45.0

7.7

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

45.0

7.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

7.7

110

591

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

4.2

7.7

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.4

7.7

104

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

5.3

7.7

KE1BG

NOMESCO Finland

MRI of prostate

5.9

7.7

WVA20

NOMESCO Finland

Medicine administration

2.1

7.7

395

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

2.3

7.6

296

H02AB09

ATC

hydrocortisone; systemic

2.1

7.6

383

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.2

7.6

121

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

18.4

7.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.6

191

1216

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

25.0

7.6

J01FF01

ATC

clindamycin; systemic

1.2

7.5

1064

9006

QDE99

SPAT

6.1

7.5

WX707

NOMESCO Finland

Fiberoscopic intubation

10.0

7.5

A99

ICPC

Disease/condition unspecnature/site

1.4

7.5

304

2151

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

7.4

937

7834

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.4

7.4

127

Kela drug reimbursment

Transplant complication

2.6

7.4

193

G04BE09

ATC

vardenafil; oral

80.2

7.4

PJW99

NOMESCO Finland

Other operation on lymphatic system

80.2

7.4

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

80.2

7.4

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

80.2

7.4

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

80.2

7.4

C44.49

ICD-10 Finland

Malignant tumor of the skin of the scalp and of the neck other or unspecified histology

80.2

7.4

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

80.2

7.4

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

7.4

153

925

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.4

7.4

230

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

7.4

934

7815

TJF80

NOMESCO Finland

Ostomy education

5.6

7.3

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

3.0

7.3

130

A91

ICPC

Abnormal result investigation NOS

1.7

7.3

154

936

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

2.2

7.3

314

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

1CD01

NOMESCO Finland

+∞

7.3

4CJ01

NOMESCO Finland

+∞

7.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

C69.09

ICD-10 Finland

Malignant tumor in conjunctival other or unspecified histology

+∞

7.3

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

7.3

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

7.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

7.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

7.3

PJ5SN

NOMESCO Finland

Sentinell SPECT with low dose CT

+∞

7.3

L01BB05

ATC

fludarabine; systemic

+∞

7.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

C44.69

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology

+∞

7.3

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

7.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

7.3

C43.1

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of eyelid, including canthus

+∞

7.3

1XC17

NOMESCO Finland

+∞

7.3

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

7.3

8721/3-C44.3

ICD-O-3

Nodular melanoma of skin of other and unspecified parts of face

+∞

7.3

C79.41

ICD-10 Finland

Secondary malignant tumor of optic nerve and eye

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

C69.90

ICD-10 Finland

Malignant tumor in unspecified localization in eye without histology

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

7.3

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

7.3

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

7.3

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

7.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

7.3

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

7.3

1726A

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MELAN EX LENTIGOMAL]

+∞

7.3

L01XE01

ATC

[U] imatinib; oral

+∞

7.3

8742/2-C44.5

ICD-O-3

Lentigo maligna of skin of trunk

+∞

7.3

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

7.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

7.3

183

1166

L04AA06

ATC

mycophenolic acid; systemic

2.3

7.3

264

AA1AD

NOMESCO Finland

CT of head and brain

1.2

7.2

1056

8965

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.6

7.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

7.2

120

1926

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.2

1230

10609

G04CA01

ATC

alfuzosin; oral

1.3

7.2

504

3911

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

7.3

7.2

J05AB01

ATC

aciclovir; systemic

1.3

7.2

761

6236

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.6

7.2

195

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

30.0

7.1

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

30.0

7.1

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

7.1

144

867

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

20.0

7.1

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.1

7.1

345

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

7.1

416

F03

ICD-10 Finland

Unspecified dementia

0.6

7.1

1359

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.2

7.0

282

OAB42

NOMESCO Finland

Guidance related to known health problem

8.8

7.0

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.1

7.0

374

QC9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in upper extremities, unspecified

10.0

7.0

H02.1

ICD-10 Finland

Ectropion of eyelid

2.5

7.0

199

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.0

7.0

438

G04BD12

ATC

mirabegron; oral

1.3

7.0

413

3125

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.8

6.9

108

601

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

5.8

6.9

D06BX01

ATC

metronidazole; topical

1.4

6.9

367

2728

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

6.8

361

L57.9

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation, unspecified

8.2

6.8

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.6

6.8

172

BAA60

NOMESCO Finland

Total thyroidectomy

2.2

6.8

294

QXA99

NOMESCO Finland

Other skin division, biopsy or local destruction, unspecified location

10.9

6.8

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.1

6.8

115

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

6.8

145

886

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

40.1

6.8

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

16.7

6.7

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

6.7

267

1882

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

6.7

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.7

117

674

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.6

6.7

1321

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

7.2

6.7

L28

ICPC

Limited function/disability (L)

1.3

6.7

668

5436

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.8

6.6

542

ZXC12

NOMESCO Finland

Pulse colorlaser

5.9

6.6

CFA20

NOMESCO Finland

Biopsy of conjunctiva

5.5

6.6

SPAT1312

SPAT

General health counselling

1.2

6.5

1258

10959

J20

ICD-10 Finland

Acute bronchitis

1.4

6.5

338

2506

A46

ICD-10 Finland

Erysipelas

1.3

6.4

581

4665

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.3

6.4

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

69.9

6.4

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

69.9

6.4

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

69.9

6.4

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

69.9

6.4

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

69.9

6.4

U77

ICPC

Malignant neopl urinary tract other

69.9

6.4

N06DA02

ATC

donepezil; oral

0.6

6.4

123

1908

D02AE01

ATC

carbamide; topical

1.5

6.4

236

1640

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

7.4

6.4

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

14.3

6.4

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.7

6.3

121

719

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.8

6.3

537

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.0

6.3

371

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

6.3

889

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

5.9

6.3

D07AB08

ATC

desonide; topical

1.3

6.3

372

2816

1XC02

NOMESCO Finland

3.8

6.3

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.2

C49.59

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor

+∞

6.2

394

Kela drug reimbursment

Palbociclib

+∞

6.2

Z85.9

ICD-10 Finland

Personal history of malignant neoplasm, unspecified

+∞

6.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

6.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.2

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

6.2

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

6.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

6.2

C43.83

ICD-10 Finland

Overall malignant melanoma of the skin nodular

+∞

6.2

L01XE21

ATC

[U] regorafenib; oral

+∞

6.2

8721/3-C44.4

ICD-O-3

Nodular melanoma of skin of scalp and neck

+∞

6.2

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

+∞

6.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

6.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

6.2

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

6.2

1726C

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,NODULARE]

+∞

6.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.2

8743/3-C44.2

ICD-O-3

Low cumulative sun damage melanoma of external ear

+∞

6.2

L01AA03

ATC

melphalan; systemic

+∞

6.2

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

6.2

1501

Kela drug reimbursment

Palbociclib

+∞

6.2

L03AB01

ATC

interferon alfa natural; parenteral

+∞

6.2

3012

Kela drug reimbursment

Cabozantinib

+∞

6.2

17241

ICD-8 Finland

Malignant melanoma of skin, Scalp and neck

+∞

6.2

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

6.2

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

6.2

C44.5

ICD-10 Finland

Malignant neoplasm: Skin of trunk

+∞

6.2

369

Kela drug reimbursment

Regorafenib

+∞

6.2

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

6.2

1502

Kela drug reimbursment

Cabozantinib

+∞

6.2

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

6.2

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

6.2

XKD10

NOMESCO Finland

Transurethral ultrasonography

+∞

6.2

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

197

Kela drug reimbursment

Sunitinib

+∞

6.2

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

6.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.2

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

6.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.2

C43.94

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin acrally

+∞

6.2

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

6.2

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

6.2

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

6.2

356

2680

QB4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in groin or genital area (from front)

26.7

6.2

JJB10

NOMESCO Finland

Atypcal resection of liver

26.7

6.2

GA5AA

NOMESCO Finland

Rib X-ray examination

4.8

6.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.5

6.1

G04BE01

ATC

alprostadil; parenteral, urethral

2.1

6.1

308

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

3.4

6.1

L01AA02

ATC

chlorambucil; oral

12.5

6.1

NF3AD

NOMESCO Finland

Femur CT

8.6

6.0

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

8.6

6.0

-44

ICPC

Preventive immunization/medic

1.4

6.0

341

2562

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.4

6.0

512

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4035726)

1805

1617

14.63

307.65

1.5

1.2

—

(40768804) Tissue Pathology biopsy report

4959

17970

6.85

307.65

3.8

1.7

—

(3002256) Pathology report gross observation

2578

4372

8.69

307.65

1.8

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1887

5599

4.23

307.65

7.4

2.7

u/l

240.6

240.2

0.02

1829

5170

(40768795) Lymph node Pathology biopsy report

208

124

17.25

251.53

1.2

1.0

—

(40768443) Skin Pathology biopsy report

816

2330

3.83

245.62

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

328

460

7.43

222.12

1.7

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

871

3080

3.08

184.70

3.7

1.5

ug/l

11.4

8.3

0.24

680

2316

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3951

27109

2.03

180.00

8.9

3.8

umol/l

11.7

12.0

0.89

3782

25308

(3044640) Blood type and Crossmatch panel - Blood

2617

15926

2.02

162.55

2.5

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4155

29797

1.95

157.77

11.6

6.3

e9/l

4.1

4.3

9.10

3613

25491

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3509

24010

1.91

151.01

4.1

3.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

333

725

4.77

142.10

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5316

42556

1.99

133.31

10.6

5.4

u/l

80.0

76.0

6.36

5023

39297

(3033658) Prothrombin time (PT) actual/Normal

2145

13140

1.91

123.31

4.2

3.5

87.9

86.4

1.80

2108

12790

(40768793) Breast Pathology biopsy report

197

305

6.61

121.37

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2672

17774

1.81

116.49

5.3

2.1

mmol/l

2.4

1.49

2325

14737

(3036481) Cortisol [Moles/volume] in Serum or Plasma

972

4543

2.32

114.77

6.3

1.8

nmol/l

377.1

368.1

0.69

927

4084

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1988

12155

1.88

113.20

2.5

2.1

—

(42870588) Differential panel, method unspecified - Blood

2698

18205

1.78

110.57

7.1

5.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

342

941

3.77

106.72

1.3

u/l

14.0

10.1

4.43

284

747

(40758558) Short blood count panel - Blood

1974

12526

1.80

97.00

9.0

4.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3442

25666

1.66

92.48

6.5

5.3

mmol/l

1.2

1.57

3127

22663

(3024561) Albumin [Mass/volume] in Serum or Plasma

3211

23594

1.66

90.78

5.9

3.8

g/l

35.2

35.5

2.07

3001

21506

(3022096) Basophils/100 leukocytes in Blood

3286

24342

1.65

89.57

7.4

5.6

0.7

0.97

3047

22377

(3006315) Basophils [#/volume] in Blood

3591

27211

1.65

89.43

7.1

5.3

e9/l

0.0

0.44

3041

23251

(40768800) Prostate Pathology biopsy report

198

413

4.90

88.74

1.2

1.1

—

(3001604) Monocytes [#/volume] in Blood

3566

27032

1.64

88.20

7.1

5.3

e9/l

0.6

2.33

3021

23078

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

23.53

87.63

1.1

1.0

ug/l

1.6

1.4

0.22

(3013115) Eosinophils [#/volume] in Blood

3673

28102

1.64

87.11

7.2

5.5

e9/l

0.2

3.96

3152

24384

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3705

28455

1.63

86.14

6.9

5.7

mmol/l

1.2

1.97

3082

23805

(3019069) Monocytes/100 leukocytes in Blood

3364

25239

1.63

85.87

7.6

5.9

8.8

8.7

0.29

3133

23289

(3006504) Eosinophils/100 leukocytes in Blood

3345

25098

1.63

85.08

7.4

5.6

2.9

3.0

0.82

3101

23044

(3019198) Lymphocytes [#/volume] in Blood

3629

27783

1.63

85.02

7.1

5.4

e9/l

2.0

1.8

1.76

3126

24151

(1617658) Protocol used for examination of sentinel lymph nodes

176.13

83.32

1.1

1.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

3408

25793

1.62

82.88

7.4

5.7

27.1

27.2

0.13

3158

23651

(3018010) Neutrophils/100 leukocytes in Blood

3349

25537

1.59

76.76

7.2

5.5

57.8

57.9

0.19

3113

23545

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

333

1118

3.08

75.61

3.2

1.9

u/ml

1605.2

85.8

1.06

290

903

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

14.08

73.23

6.3

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1590

10150

1.73

73.20

4.6

2.2

mmol/l

2.5

2.4

2.82

1412

8661

(3018418) pH of Serum or Plasma

2331

16520

1.61

71.26

5.0

3.4

7.4

0.02

466

2891

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1338

8215

1.77

70.30

3.5

2.4

mmol/l

0.8

0.51

1239

7506

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5962

52868

1.80

69.61

18.5

12.5

ml/min/173m2

76.0

76.2

0.33

5185

42732

(3013826) Glucose [Moles/volume] in Serum or Plasma

4128

33658

1.54

65.97

5.6

4.4

mmol/l

6.7

6.8

4.07

3940

31373

(3021589) Normoblasts [#/volume] in Blood

3111

24005

1.53

63.19

11.7

8.7

e9/l

0.0

0.39

2533

19609

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

9.51

55.94

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

3046

23831

1.49

55.36

10.1

10.6

inr

1.3

1.66

851

6596

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6150

56007

1.74

52.99

18.4

13.6

mg/l

25.0

24.0

1.39

5098

44076

(3023368) Bacteria identified in Blood by Culture

2082

15283

1.51

50.49

4.5

3.9

—

(36304419) Bacteria [Presence] in Urine

2045

14957

1.52

50.45

3.7

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6409

59277

1.84

49.56

21.6

16.6

mmol/l

4.0

6.95

6266

57575

(3019550) Sodium [Moles/volume] in Serum or Plasma

6395

59135

1.83

49.11

21.3

16.5

mmol/l

139.7

139.8

0.55

6264

57541

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

27.62

48.42

1.1

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4374

37242

1.46

48.40

4.7

4.5

e6/l

1332.7

2008.9

0.34

572

(3042936) Bacteria identified in Isolate by Culture

1172

7626

1.64

47.77

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

2248

16935

1.48

47.32

3.7

3.1

e6/l

103.9

112.1

0.07

1759

12894

(3030467) Casts [#/volume] in Urine by Automated count

2097

15596

1.49

47.01

3.7

3.0

e6/l

0.4

0.5

0.15

1619

11641

(3018095) Leukocytes [#/volume] in Urine

2559

19800

1.46

46.81

4.2

3.5

e6/l

94.7

108.1

0.40

1875

13914

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6433

59905

1.79

43.90

13.9

9.3

u/l

25.5

25.4

0.04

6220

57251

(3007853) Bacteria identified in Skin by Aerobe culture

1010

6496

1.65

42.69

1.8

—

(3003694) ABO and Rh group [Type] in Blood

1791

13152

1.48

41.83

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

176

5.05

41.50

5.3

1.1

u/ml

113.6

195.8

0.44

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2205

16885

1.44

41.32

3.9

2.6

u/l

34.1

34.2

0.01

2078

15862

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

702

4142

1.77

40.67

2.1

2.0

g/l

0.2

3.10

655

3744

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

152

464

3.33

40.44

1.5

1.3

u/l

32.8

32.1

0.09

143

337

(3017446) Testosterone [Moles/volume] in Serum or Plasma

578

3231

1.86

40.00

2.0

2.2

nmol/l

11.5

14.4

12.64

505

2803

(40761511) CBC panel - Blood by Automated count

6257

58081

1.66

39.88

16.7

13.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

762

4645

1.72

39.27

2.8

2.2

u/l

33.4

50.0

0.92

669

3918

(3023323) Follitropin [Units/volume] in Serum or Plasma

317

1435

2.27

39.15

1.3

iu/l

27.8

32.2

1.56

260

1245

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2275

17676

1.42

38.78

4.4

2.3

u/l

57.8

59.6

1.06

2086

16161

(3007461) Platelets [#/volume] in Blood

6580

62034

1.84

38.29

27.6

20.0

e9/l

244.5

244.8

0.13

6436

60120

(3024731) MCV [Entitic volume]

6580

62055

1.83

37.95

27.5

19.9

91.3

91.4

1.06

6491

60927

(3026361) Erythrocytes [#/volume] in Blood

6580

62062

1.83

37.83

27.5

20.0

e12/l

4.5

4.73

6424

59910

(3000963) Hemoglobin [Mass/volume] in Blood

6580

62071

1.83

37.68

27.7

20.1

g/l

134.2

135.8

15.00

6497

60956

(3035941) MCH [Entitic mass]

6578

62055

1.83

37.55

27.4

19.9

30.3

30.4

3.83

6489

60928

(3010813) Leukocytes [#/volume] in Blood

6579

62074

1.82

37.44

27.6

20.0

e9/l

6.8

0.93

6421

59919

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

345

1649

2.15

37.24

2.5

1.5

u/ml

37.6

27.5

0.60

331

1562

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1253

8726

1.53

37.21

3.3

2.8

e6/l

1.8

2.5

3.11

696

4713

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

7.78

36.95

10.5

1.5

u/l

57.8

52.2

0.11

(3021387) Prolactin [Units/volume] in Serum or Plasma

260

1121

2.37

35.96

1.8

1.7

mu/l

298.1

300.3

0.04

243

1021

(3026782) Osmolality of Urine

1493

10901

1.47

34.91

3.1

2.7

mosm/kgh2o

546.6

548.7

0.14

1292

9105

(40768441) Liver Pathology biopsy report

220

4.18

34.04

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

878

5750

1.60

33.94

3.6

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

708

4422

1.67

33.06

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

795

5139

1.62

32.35

1.6

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

1577

11865

1.42

30.85

2.9

2.5

e6/l

4.4

4.9

1.03

1394

10245

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

849

5649

1.57

30.47

2.9

2.2

umol/l

9.1

7.9

0.82

744

4836

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

263

1224

2.19

30.36

1.5

1.8

iu/l

3.7

4.4

0.37

408

(3002385) Erythrocyte distribution width [Ratio]

5013

45271

1.37

29.77

22.8

16.2

13.8

13.7

5.98

4945

44148

(3037467) Urinalysis macro (dipstick) panel - Urine

4417

39218

1.33

28.78

4.6

4.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

470

2734

1.77

28.31

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1301

9614

1.43

27.73

3.2

2.6

e6/l

1.6

1.2

0.58

744

5556

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1012

7140

1.49

27.46

6.9

5.4

mmol/l

1.0

0.13

947

6536

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4775

43095

1.33

26.50

4.8

3.9

pmol/l

15.0

14.9

2.34

4293

38749

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

178

746

2.42

26.29

4.7

5.3

iu/ml

569.8

852.9

0.34

107

(3014576) Chloride [Moles/volume] in Serum or Plasma

989

7018

1.48

25.96

7.2

6.5

mmol/l

104.3

0.17

978

6841

(3049717) Cytology report of Urine Cyto stain

356

1962

1.86

25.61

2.7

1.8

—

(3044889) 12 lead EKG panel

4522

40679

1.31

24.61

4.5

4.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

143

562

2.58

24.24

2.8

2.5

u/ml

535.1

622.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

724

4881

1.54

24.24

6.0

6.6

mmol/l

1.4

0.22

696

4689

(3020779) Urea [Moles/volume] in Serum or Plasma

741

5025

1.53

24.14

8.0

6.9

mmol/l

10.6

11.0

0.80

710

4723

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5622

52270

1.36

23.72

5.9

4.7

mu/l

2.0

2.1

1.38

5096

47316

(3009542) Hematocrit [Volume Fraction] of Blood

5350

49434

1.33

23.04

20.0

15.0

39.6

39.4

0.87

3661

32556

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

293

3.17

23.00

1.3

—

(40768806) Pleura Pathology biopsy report

120

446

2.72

22.75

1.8

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1175

8825

1.40

22.33

2.1

1.9

30.3

30.0

0.70

1134

8541

(21494815) CD4 cells/100 lymphocytes in Specimen

248

3.33

22.30

1.6

2.1

37.4

42.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

224

3.46

22.25

2.3

1.9

e6/l

525.0

711.9

1.32

101

(3000991) Gas panel - Venous blood

673

4549

1.53

22.19

8.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

459

2838

1.66

22.07

7.8

9.1

mmol/l

24.4

24.5

0.26

435

2587

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

9.03

22.06

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

197

942

2.12

21.31

3.9

3.4

57.7

58.5

0.38

197

942

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

472

2998

1.62

20.37

3.9

2.9

pmol/l

4.4

0.94

431

2600

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1582

12606

1.33

20.33

3.6

2.8

ug/l

0.8

0.7

1.03

1178

8783

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.96

19.92

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1510

11994

1.33

19.76

4.7

4.0

ng/l

177.4

529.5

8.44

1255

9878

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

150

667

2.28

19.46

3.4

2.0

u/ml

107.0

487.0

0.88

138

604

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1218

9412

1.36

19.11

1.8

—

(3022145) Colonoscopy Study observation

789

5680

1.44

18.85

1.3

—

(3045142) Bone marrow Pathology biopsy report

104

398

2.64

18.70

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

525

3494

1.54

18.51

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

148

670

2.23

18.42

3.6

2.8

1.1

1.2

0.21

114

501

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

109

435

2.53

18.01

1.9

1.8

u/ml

82.3

366.4

0.44

109

420

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

236

1281

1.87

17.87

2.6

2.3

g/l

3.6

0.01

228

1202

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

309

1836

1.71

17.27

2.6

3.0

u/ml

0.4

0.3

0.19

178

1076

(3013707) Erythrocyte sedimentation rate by Westergren method

4626

42559

1.25

16.93

4.2

mm/h

12.8

12.5

0.66

4235

39088

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2699

23419

1.25

16.92

2.2

nmol/l

79.9

78.7

1.27

2360

20523

(3013512) EKG study

2105

17764

1.26

16.81

4.4

4.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

349

2161

1.65

16.69

2.8

2.3

ug/l

395.6

686.9

1.53

334

2034

(46235355) HIV 1 and 2 tests - Meaningful Use set

821

6094

1.39

16.38

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

263

1521

1.76

16.19

1.6

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

137

637

2.17

16.02

1.7

1.5

g/l

31.5

29.0

1.65

121

555

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5906

56090

1.32

16.00

5.3

5.0

mmol/l

6.0

3.34

5305

50726

(40760892) CBC W Ordered Manual Differential panel - Blood

1400

11313

1.30

15.69

5.2

4.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

225

1255

1.82

15.66

2.7

2.3

196.9

191.2

0.39

212

1184

(3028308) Erythrocytes [#/volume] in Pleural fluid

118

522

2.28

15.58

1.6

1.5

e6/l

62622.9

58747.1

0.06

306

(3027945) Reticulocytes/100 erythrocytes in Blood

878

6641

1.37

15.56

2.7

2.1

1.8

0.72

775

5754

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

462

3108

1.52

15.48

1.3

1.2

iu/ml

129.8

130.0

0.00

116

1173

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

237

1348

1.78

15.47

2.2

2.0

91.6

90.4

0.31

220

1254

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2245

19239

1.24

15.35

3.0

3.1

ng/l

1698.1

1548.1

0.52

1941

16567

(3026493) Urate [Moles/volume] in Serum or Plasma

1873

15743

1.26

15.16

3.0

2.5

umol/l

5325.5

5952.2

0.23

1604

13362

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

312

2.65

15.00

1.3

u/l

10.4

11.6

0.48

279

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1003

7799

1.33

14.78

2.9

2.7

22.5

22.4

0.06

880

6505

(3023199) Leukocytes [#/volume] in Pleural fluid

125

581

2.17

14.67

1.6

1.5

e6/l

1668.5

2697.3

1.03

426

(3012441) Differential panel - Pleural fluid

109

481

2.29

14.51

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

630

4566

1.42

14.38

5.3

3.1

mmol/l

1.2

0.34

555

3840

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

188

1022

1.86

14.25

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

845

6438

1.35

14.24

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

659

4843

1.40

13.87

2.9

1.6

g/l

65.8

66.8

2.33

590

4282

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2573

22547

1.22

13.86

5.8

4.0

ug/l

3.3

2.3

1.60

2276

20162

(3036489) Thrombin time

292

1813

1.64

13.85

2.1

1.8

21.4

21.5

0.09

265

1576

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1060

8387

1.31

13.73

2.7

2.6

g/l

2.3

1.76

985

7672

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2229

19283

1.23

13.54

2.4

2.2

u/l

188.3

236.0

2.16

2103

17970

(3023520) Reticulocytes [#/volume] in Blood

665

4953

1.38

12.89

2.8

2.1

e9/l

68.9

68.7

0.06

474

3765

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

392

2665

1.50

12.51

4.8

4.1

mmol/l

24.2

0.09

360

2360

(3052851) Hemolysis interference index of Serum or Plasma

267

1680

1.61

12.05

3.6

3.4

—

(40761536) Microorganisms panel - Urine sediment

604

4482

1.38

11.97

4.6

4.0

—

(3019225) pH of Specimen

762

5863

1.34

11.95

4.6

3.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

527

2.08

11.65

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3780

34701

1.19

11.61

3.2

3.0

u/l

52.1

47.5

1.92

3468

31726

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

605

4513

1.37

11.60

4.1

3.8

ng/l

105.4

95.3

1.29

517

3787

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

168

2.99

11.60

2.8

2.3

32.7

42.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

393

2718

1.47

11.53

1.8

1.6

g/l

1.5

0.58

336

2316

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

490

2.12

11.49

4.2

3.0

—

(4281824)

278

2.50

11.33

1.2

—

(40765096) Chromosome analysis panel by Banding

4.12

11.30

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

582

4341

1.37

11.16

4.4

3.7

1.0

0.8

0.94

184

942

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.25

11.05

1.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

146

797

1.85

11.02

1.5

1.4

—

(3026008) Bacteria identified in Urine by Culture

1993

17335

1.21

10.95

3.1

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

829

6539

1.30

10.85

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

256

1645

1.58

10.62

2.2

1.5

g/l

0.0

0.50

221

1478

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

298

1982

1.53

10.60

2.6

1.5

g/l

1.1

0.5

1.74

243

1675

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

307

2.36

10.49

1.6

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

828

6563

1.30

10.43

1.7

—

(3045788) Cell count panel - Pleural fluid

443

2.11

10.38

1.7

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

5.13

10.30

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

722

1.86

10.25

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

135

738

1.85

10.18

1.1

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

556

4179

1.36

10.16

4.4

3.8

0.1

0.78

172

876

(3022948) Iron [Moles/volume] in Serum or Plasma

1107

9134

1.25

10.01

2.8

2.6

umol/l

12.6

12.8

0.53

1026

8349

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

1615

1.56

9.94

2.2

1.5

g/l

0.0

0.00

220

1472

(3002179) Metamyelocytes/100 leukocytes in Blood

531

3980

1.36

9.88

4.1

3.6

0.6

0.5

0.15

137

706

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

141

792

1.80

9.75

1.8

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

266

1760

1.53

9.72

2.2

1.5

g/l

0.0

0.93

231

1590

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

422

2.10

9.69

1.4

1.3

u/l

411.0

299.0

0.98

397

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2059

18148

1.19

9.52

4.8

3.9

22.1

24.3

9.77

1110

9019

(3017354) Segmented neutrophils/100 leukocytes in Blood

452

2.05

9.51

3.3

2.7

56.7

60.7

0.74

294

(3003396) Base excess in Arterial blood by calculation

822

6587

1.28

9.48

6.2

6.9

mmol/l

0.9

1.3

2.72

660

5082

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

9.37

1.1

0.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

188

1157

1.64

9.36

1.8

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

824

6616

1.28

9.35

6.2

6.9

kpa

12.7

11.6

7.38

788

6271

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

272

1824

1.51

9.35

2.4

2.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1866

1.50

9.31

2.1

1.5

g/l

37.8

37.6

0.27

230

1559

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

824

6621

1.28

9.30

6.2

6.9

kpa

5.1

0.03

788

6292

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

508

3819

1.36

9.28

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

128

711

1.81

9.21

1.5

u/ml

111.1

121.6

0.41

140

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2545

22884

1.17

9.20

3.0

2.9

ug/l

146.5

130.5

1.86

2314

20905

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2638

23795

1.17

9.17

4.1

3.9

ng/l

42.3

85.3

2.11

1976

17187

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

333

2.20

9.14

1.4

u/l

13.0

0.02

318

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1706

14864

1.19

8.88

2.3

mg/l

3.0

0.21

1451

12601

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

318

2225

1.45

8.85

2.3

1.5

g/l

3.1

3.0

0.39

239

1702

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

334

2363

1.43

8.76

2.1

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

472

3551

1.35

8.59

3.2

2.3

g/l

10.3

10.9

1.32

428

3234

(3011412) CD3 cells [#/volume] in Blood

287

2.24

8.38

2.5

2.0

e9/l

1.1

0.19

162

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3270

30143

1.16

8.28

2.5

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

336

2.12

8.16

1.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1048

8780

1.23

8.13

28.4

29.2

inr

1.3

1.5

1.16

112

1183

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5975

57775

1.22

8.09

5.3

mmol/l

2.7

0.10

5385

52942

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

137

808

1.71

8.07

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

200

1298

1.56

8.04

3.7

2.7

mg/l

1.7

0.03

188

1143

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2372

1.41

7.95

2.3

1.4

g/l

3.5

3.9

4.98

239

1664

(3025159) Blasts/100 leukocytes in Blood

515

3972

1.32

7.93

4.3

3.8

0.1

0.3

0.55

146

772

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2376

1.41

7.88

2.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

535

1.86

7.84

1.2

u/l

53.3

57.3

0.27

335

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

230

1548

1.50

7.83

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2379

1.41

7.82

2.3

1.4

g/l

7.3

7.5

1.31

246

1733

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2845

26033

1.16

7.80

2.1

pmol/l

94.2

94.5

0.14

1476

13364

(3047189) Immunofixation for 24 hour Urine

216

2.37

7.65

1.7

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1403

12153

1.19

7.65

1.8

1.7

mg/l

1.5

1.2

0.96

1093

9291

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

112

2.96

7.63

1.1

1.3

ug/l

15.7

69.2

0.80

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

310

2221

1.41

7.62

2.3

1.5

g/l

9.9

10.4

1.25

249

1833

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

353

2.05

7.57

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

230

1560

1.49

7.55

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5800

56009

1.19

7.52

4.7

mmol/l

1.5

0.06

5230

51190

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

305

2185

1.41

7.51

1.8

1.7

—

(3036603) Volume of Urine

343

2.05

7.38

1.5

1.4

1950.5

1963.3

0.02

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5841

56461

1.20

7.38

4.7

4.8

mmol/l

4.6

4.5

0.03

5297

51953

(42529406) Shigella sp [Presence] in Stool by Culture

230

1570

1.48

7.33

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5621

54172

1.18

7.27

4.2

mmol/l

1.3

0.13

5019

49083

(3036782) Glucose [Moles/volume] in Pleural fluid

422

1.93

7.20

1.5

1.4

mmol/l

6.2

6.7

0.59

382

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.76

7.07

3.2

1.3

pmol/l

66.3

51.4

0.17

(40758292) HTLV I+II Ab panel - Serum

4.58

6.92

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

231

1605

1.45

6.76

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

169

1101

1.55

6.75

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

482

1.84

6.74

1.8

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

210

2.29

6.74

1.7

1.9

16.7

16.2

0.07

(3021960) Folate [Moles/volume] in Serum or Plasma

1663

14749

1.17

6.72

1.6

1.5

nmol/l

20.4

20.3

0.08

1390

12453

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

150

2.54

6.66

2.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

658

5362

1.25

6.57

7.1

7.7

g/l

120.5

122.6

1.95

637

5157

(3037756) Immunofixation for Serum or Plasma

173

1142

1.53

6.52

1.7

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.96

6.52

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

164

2.45

6.49

2.6

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

431

3340

1.31

6.45

1.5

—

(3051651) Icteric interference index of Serum or Plasma

273

2.10

6.43

4.8

4.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

215

2.24

6.40

1.8

1.9

69.3

72.0

0.46

203

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

126

776

1.63

6.39

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5594

54045

1.17

6.33

6.3

6.4

mmol/mol

40.1

40.6

4.12

5069

49650

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

6.67

6.31

6.2

4.1

umol/l

0.3

0.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.84

6.25

1.6

1.3

ng/l

78.9

93.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

526

4201

1.27

6.24

2.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

1138

1.52

6.23

1.7

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.01

6.22

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

150

2.47

6.17

2.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

150

2.47

6.17

2.6

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

150

2.47

6.17

4.0

2.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

390

1.88

6.09

1.3

nmol/l

0.3

0.27

308

(1616796) Gas panel - Central venous blood

185

1259

1.48

6.06

3.4

3.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

377

2902

1.32

5.94

8.7

9.8

—

(3035880) pH of Pleural fluid

264

2.05

5.81

1.2

1.3

—

(3016502) Oxygen saturation in Arterial blood

715

5965

1.22

5.74

6.7

7.2

96.1

95.2

5.57

691

5727

(3019150) Specific gravity of Urine by Refractometry

1120

12813

0.85

5.70

4.1

4.2

kg/l

1.0

0.34

157

1941

(3051611) Lipemic interference index of Serum or Plasma

566

1.69

5.53

4.2

3.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

729

1.60

5.49

1.3

1.2

u/ml

248.4

286.6

0.93

460

(3008295) Osmolality of Serum or Plasma

526

1.70

5.35

1.3

1.4

mosm/kgh2o

282.5

276.8

1.77

397

(40768797) Stomach Pathology biopsy report

909

7812

1.19

5.32

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.55

5.31

1.1

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

113

2.57

5.28

1.3

2.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

108

675

1.61

5.24

2.3

1.7

33.6

32.7

1.33

108

670

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

201

2.15

5.23

2.9

1.9

e9/l

0.3

0.2

0.62

180

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

2.09

5.22

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

2.09

5.22

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

524

1.69

5.16

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

442

1.75

5.15

1.9

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

177

2.21

5.11

34.5

33.5

ug/l

6.8

7.5

1.41

164

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

887

7635

1.18

5.09

4.9

33.1

33.0

0.15

571

5093

(3016650) Hepatitis A virus Ab [Presence] in Serum

112

712

1.58

5.08

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

157

1076

1.47

5.03

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

211

2.09

5.03

2.8

1.9

e6/l

541.5

442.7

0.77

182

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

2.13

5.02

2.3

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

769

6557

1.19

4.92

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.48

4.88

1.4

1.2

32.6

26.0

—

(3016228) CD19 cells/100 cells in Blood

118

2.46

4.86

1.4

2.1

10.0

7.7

0.36

113

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

283

1.92

4.85

1.3

1.2

u/l

39.5

19.8

1.17

233

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

201

2.10

4.84

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

208

2.07

4.82

2.5

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

208

2.07

4.82

2.4

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

208

2.07

4.82

2.5

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

208

2.07

4.82

2.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

513

1.66

4.77

1.2

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

550

4560

1.22

4.72

3.4

2.4

ml/min/173m2

59.0

62.8

1.53

237

1771

(3023410) Appearance of Cerebral spinal fluid

470

1.69

4.69

1.2

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

356

2814

1.28

4.66

2.3

1.4

g/l

1.4

1.2

0.57

316

2544

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

158

1102

1.44

4.66

1.5

1.6

—

(3012501) Base excess in Blood by calculation

175

1253

1.41

4.48

4.2

4.1

mmol/l

2.5

0.08

116

841

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

293

1.85

4.40

1.3

1.2

u/l

107.1

83.7

0.95

246

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

117

780

1.51

4.35

2.1

2.2

mg/l

25.2

25.6

0.02

195

(3010421) pH of Blood

200

1473

1.37

4.34

4.5

4.1

7.4

0.08

173

1222

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

204

2.02

4.30

1.1

ug/l

2.6

2.7

0.02

172

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.04

4.23

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.04

4.23

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.04

4.23

1.2

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

174

1260

1.39

4.20

1.4

1.3

—

(3002032) Base excess in Venous blood by calculation

654

5585

1.19

4.13

4.1

3.7

mmol/l

1.8

1.9

0.33

546

4547

(21494890) Protein electrophoresis panel - 24 hour Urine

551

1.59

4.09

2.1

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

397

1.69

4.09

2.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

397

1.69

4.09

2.0

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

397

1.69

4.09

2.0

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

323

1.77

4.07

1.7

1.5

u/l

9.8

7.5

0.19

138

(3000093) Morphology [Interpretation] in Blood Narrative

513

1.61

4.06

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.60

3.96

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

439

1.65

3.96

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

326

1.75

3.95

1.7

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.82

3.95

5.7

4.9

ug/min

74.8

42.9

0.75

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

406

3333

1.23

3.88

1.3

au/ml

56.2

46.7

0.24

143

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

285

2247

1.28

3.87

1.8

ug/l

1.7

0.02

241

1945

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

442

3663

1.22

3.86

2.5

2.4

au/ml

34.5

24.3

0.65

161

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

227

1.90

3.85

1.3

—

(3037121) Protein [Mass/volume] in Urine

238

1836

1.31

3.82

3.1

2.5

g/l

0.3

0.77

117

632

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

167

1223

1.37

3.80

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

167

1223

1.37

3.80

1.3

—

(3042631) Mycobacterium sp identified in Specimen

107

724

1.49

3.76

2.3

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

2954

27913

1.10

3.76

4.8

5.0

estimate

0.0

0.80

613

4827

(3021447) Carbon dioxide [Partial pressure] in Venous blood

651

5606

1.18

3.74

4.1

3.7

kpa

5.9

5.8

0.64

635

5434

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

377

1.68

3.74

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

332

1.72

3.73

1.1

1.2

mg/l

88.3

38.2

0.71

281

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.91

3.73

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

121

2.24

3.72

2.0

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.45

3.71

1.5

2.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

312

1.74

3.64

1.1

mg/l

503.4

275.5

0.84

278

(3011985) Renin [Units/volume] in Plasma

109

746

1.47

3.63

1.5

1.3

mu/l

33.5

61.6

2.43

660

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

560

1.54

3.63

1.3

1.4

—

43.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.75

3.58

2.4

1.8

e6/l

699.2

171.3

0.45

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

143

1032

1.39

3.58

5.0

3.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

208

1593

1.31

3.55

1.4

ug/g

284.3

290.0

0.17

134

959

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

157

1153

1.37

3.54

1.2

1.3

e6/l

9.7

24.4

1.42

116

911

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

500

1.57

3.54

3.3

2.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

124

2.18

3.53

1.6

2.3

e6/l

30662.5

28778.1

0.02

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

157

1154

1.37

3.52

1.3

1.4

e6/l

422.1

1215.1

1.61

124

959

(3009261) Glucose [Presence] in Urine by Test strip

2981

28243

1.10

3.51

3.7

3.8

estimate

0.0

1.60

598

4660

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

100

678

1.48

3.51

6.3

mg/l

11.6

12.1

0.54

602

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

100

679

1.48

3.48

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

165

1225

1.36

3.48

1.2

1.1

—

(4027681)

243

1.82

3.47

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

281

1.75

3.41

1.2

1.1

u/l

27.0

23.5

0.19

201

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

212

1638

1.30

3.41

1.5

g/l

1.2

0.23

202

1539

(3007164) IgA [Mass/volume] in Serum or Plasma

1061

9537

1.13

3.38

1.7

1.3

g/l

2.3

2.6

2.86

601

5410

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

282

1.74

3.38

1.2

1.1

u/l

86.5

83.6

0.08

211

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

2.25

3.37

3.3

2.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

280

2249

1.26

3.31

1.9

1.8

u/l

40.2

38.4

0.71

247

1917

(3035350) Ketones [Presence] in Urine by Test strip

2943

27921

1.09

3.30

3.6

3.7

estimate

0.0

0.80

602

4754

(3004716) Salmonella sp identified in Stool by Organism specific culture

282

2268

1.25

3.30

1.2

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.54

3.29

4.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

639

1.48

3.28

1.7

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

102

2.26

3.28

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

109

2.21

3.24

2.0

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

169

1276

1.33

3.22

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

642

1.47

3.21

1.7

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

139

1019

1.37

3.21

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

660

1.46

3.18

1.1

g/l

1.4

1.5

2.59

583

(3001964) Herpes simplex virus Ag [Presence] in Specimen

130

2.08

3.17

1.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

1873

1.27

3.11

4.1

1.5

ratio

1.4

2.3

1.19

162

(3025941) Bacteria identified in Stool by Culture

347

2875

1.22

3.10

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.89

3.02

1.8

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

178

1370

1.31

2.99

1.3

1.2

titre

393.3

155.8

0.62

113

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

241

1930

1.26

2.96

4.1

1.5

mg/l

56.3

37.4

0.53

196

1543

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

178

0.28

2.95

2.2

2.6

nmol/l

152.8

145.1

—

157

(3025468) Yersinia sp identified in Specimen by Organism specific culture

639

1.45

2.92

1.7

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

241

1934

1.25

2.92

4.2

1.6

mg/l

51.7

47.9

0.31

194

1553

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

1.70

2.91

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.67

2.86

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

6.67

2.86

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.50

2.86

1.6

1.4

14.9

7.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

894

1.37

2.86

1.4

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

660

1.43

2.83

1.1

1.3

nmol/l

—

(3024928) Oxygen saturation in Venous blood

163

1251

1.31

2.82

2.8

3.2

—

(3012565) Volume of 24 hour Urine

268

1.68

2.80

2.9

2.1

1777.6

1957.8

0.65

231

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

1.93

2.74

1.8

2.6

e6/l

22001.2

642.4

0.64

106

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.00

2.72

8.0

4.7

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

5.00

2.72

1.9

1.3

ug/l

95.0

200.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

167

1.86

2.70

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

701

1.40

2.68

1.4

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.75

2.67

1.0

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

176

1381

1.28

2.60

1.3

1.2

titre

395.7

1088.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

236

1.70

2.60

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

169

1320

1.29

2.59

1.3

1.2

mg/l

552.1

540.2

0.11

157

1243

(40767503) Oxygen content in Capillary blood by calculation

156

1208

1.30

2.56

2.4

2.5

15.7

16.4

1.24

654

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

649

1.41

2.55

1.7

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

128

1.96

2.54

2.4

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

862

1.35

2.54

1.2

—

(3042733) HLA Ab [Presence] in Serum

143

1.89

2.50

5.1

5.3

—

(3014271) Vancomycin [Susceptibility]

364

1.54

2.49

2.8

3.0

—

(3048879) Bone marrow aspiration report

129

1.94

2.49

2.1

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

102

745

1.37

2.49

1.2

1.3

nmol/l

0.7

4.1

0.98

715

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.81

2.46

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

296

1.59

2.41

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

699

1.38

2.40

1.3

pmol/l

304.4

271.5

0.42

520

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.34

2.39

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

2.39

8.4

1.0

—

(44790047)

541

1.43

2.37

1.4

—

(44790048)

541

1.43

2.37

1.4

—

(44790049)

541

1.43

2.37

1.4

—

(44806118)

541

1.43

2.37

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

139

1.87

2.35

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

102

753

1.36

2.35

1.2

nmol/l

0.2

0.4

0.83

(3045414) Leukocytes [Presence] in Urine

309

2609

1.19

2.34

1.8

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

161

1.80

2.34

1.6

1.4

59.3

62.0

0.16

131

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

460

1.46

2.33

2.0

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

653

1.38

2.31

1.7

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

284

1.59

2.30

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

198

1604

1.24

2.28

1.6

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

285

1.58

2.27

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

174

1391

1.26

2.26

1.3

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.28

2.24

1.1

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

1.83

2.22

2.0

u/ml

288.0

82787.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

135

1.85

2.21

1.6

1.5

4.1

2.6

0.32

113

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

1.93

2.20

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

304

1.55

2.18

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.13

2.18

10.9

11.7

mmol/l

4.4

5.3

1.28

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

345

1.51

2.16

1.4

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

101

1.98

2.15

2.3

1.8

11.0

9.0

0.23

(3009343) pH of Capillary blood

426

3722

1.15

2.14

3.6

3.5

7.4

0.30

465

(3048689) Calprotectin [Mass/mass] in Stool

668

6012

1.12

2.13

2.1

2.2

ug/g

137.3

144.0

0.15

522

4694

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

338

1.51

2.13

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

672

1.36

2.13

1.7

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.71

2.10

5.3

3.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.20

2.09

8.9

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

142

1120

1.27

2.09

2.4

2.5

umol/l

32.8

33.8

0.18

118

949

(3007930) Methemoglobin/Hemoglobin.total in Blood

209

2524

0.82

2.08

3.6

4.8

0.9

0.03

194

2369

(3018834) Bilirubin.total [Presence] in Urine by Test strip

5.00

2.07

3.6

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

212

2555

0.82

2.07

3.5

4.7

1.5

1.6

1.27

195

2399

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.91

2.07

2.2

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

245

1.60

2.06

1.4

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

245

1.60

2.06

1.4

1.2

—

(3006270) Folate [Moles/volume] in Blood

592

0.64

2.05

1.1

1.2

nmol/l

352.7

343.5

0.12

472

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

687

1.34

2.02

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

172

1394

1.24

2.01

1.9

mg/l

11.7

11.4

0.24

162

1277

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

430

3779

1.15

2.01

3.6

3.5

kpa

5.1

5.2

1.84

399

3469

(3025130) Human papilloma virus identified in Specimen

484

1.41

2.00

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.96

1.99

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.34

1.96

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

145

1158

1.26

1.94

1.2

mmol/l

3.7

3.9

1.01

135

1083

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

134

1.79

1.94

1.1

80.0

89.7

0.51

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

410

3601

1.15

1.94

3.6

3.4

mmol/l

1.5

1.9

0.96

303

2648

(3047007) Chlamydophila sp Ab [Presence] in Serum

650

1.34

1.92

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1355

12693

1.08

1.92

1.8

nmol/l

1145.7

1154.6

0.12

976

9513

(3011648) Oxygen content in Venous blood

438

1.42

1.91

1.9

2.2

10.6

11.0

0.23

438

(3011397) Hemoglobin [Presence] in Urine by Test strip

1458

13700

1.08

1.91

3.4

3.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

529

5900

0.89

1.89

1.7

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.18

1.88

1.0

—

(1002224) Polysomnography panel

222

1863

1.20

1.87

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

825

0.71

1.85

2.5

2.1

—

(3041354) Potassium [Moles/volume] in Venous blood

836

0.72

1.84

2.5

2.1

mmol/l

4.1

0.05

829

(3035285) Chloride [Moles/volume] in Venous blood

836

0.72

1.84

2.5

2.1

mmol/l

106.0

105.9

0.02

829

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

384

3374

1.15

1.83

2.6

2.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

115

1.83

1.82

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

105

1345

0.78

1.82

1.1

u/ml

4.7

9.1

0.65

129

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

343

1.46

1.81

1.1

1.0

nmol/l

3.9

7.4

0.83

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.05

1.80

1.6

2.1

mg/l

4.4

3.2

—

(3014051) Protein [Presence] in Urine by Test strip

165

1351

1.23

1.79

2.0

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

871

8029

1.10

1.79

7.9

7.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

263

1.52

1.78

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

263

1.52

1.78

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

427

3788

1.14

1.77

2.9

e9/l

4.1

0.06

304

2745

(40768446) Kidney Pathology biopsy report

192

1.62

1.77

2.0

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

522

4690

1.12

1.76

3.0

3.1

kpa

4.6

4.5

0.78

503

4530

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

102

1.87

1.75

2.4

1.7

33.6

26.8

0.95

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

264

1.52

1.75

1.3

1.4

—

(3016750) Collection duration of Urine

379

1.43

1.75

2.6

2.1

min

489.0

499.7

0.32

290

(3022475) Manganese [Moles/volume] in Blood

3.34

1.74

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.98

1.74

1.1

—

(3017569) Oxygen content in Arterial blood

322

0.56

1.72

1.4

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

847

9165

0.91

1.71

1.2

1.3

u/ml

14.1

13.9

0.02

303

3417

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

423

1.40

1.71

1.2

1.3

mmol/l

11.7

11.9

0.04

111

(3008536) Aspergillus sp Ab [Presence] in Serum

2.00

1.69

2.5

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

112

886

1.27

1.67

1.8

1.9

mmol/l

1.5

1.7

1.18

107

867

(3003740) Influenza virus B Ag [Presence] in Specimen

553

1.34

1.67

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

493

1.36

1.67

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

808

0.73

1.66

3.9

4.5

umol/l

326.7

359.1

0.94

680

(3002523) Influenza virus A Ag [Presence] in Specimen

554

1.34

1.65

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

511

1.35

1.65

1.1

—

56.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.80

1.65

2.7

3.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.93

1.64

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

138

1688

0.81

1.63

4.0

4.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

169

1404

1.21

1.62

3.4

3.2

nmol/l

0.8

0.61

134

1090

(3005322) IgE [Units/volume] in Serum or Plasma

358

3161

1.14

1.62

1.2

1.3

u/ml

125.4

233.3

5.64

332

2920

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

697

1.29

1.60

1.2

u/ml

4.7

4.5

0.05

303

(3023419) Bacteria identified in Sputum by Culture

766

0.73

1.58

2.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.00

1.58

1.0

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

533

1.34

1.57

1.1

—

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

411

3670

1.13

1.57

1.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

495

0.67

1.56

1.0

ng/l

269.6

336.4

0.77

327

(4268621)

474

1.35

1.55

2.4

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

311

0.58

1.55

1.3

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.27

1.53

2.6

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1295

13712

0.93

1.53

1.7

pmol/l

25486822.8

31902932.3

0.16

1028

11159

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.67

1.51

1.0

1.1

79.4

88.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

425

1.37

1.51

1.3

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.86

1.50

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1639

15600

1.07

1.49

1.6

mmol/l

1.3

0.08

1342

12882

(3030981) Hyaline casts [#/volume] in Urine by Automated count

343

3040

1.13

1.49

2.7

2.6

e6/l

0.2

0.3

0.57

336

2969

(4034850)

175

2071

0.84

1.49

10.8

10.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

501

0.68

1.48

1.0

ng/l

33.3

45.6

1.45

323

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.48

2.4

1.7

—

(3000492) Spirometry study

541

4928

1.11

1.46

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

283

2480

1.15

1.46

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

498

0.68

1.44

1.0

ng/l

537.4

718.6

1.97

317

(3020891) Body temperature

282

2474

1.15

1.43

4.7

4.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

752

0.74

1.43

1.2

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.97

1.43

1.2

ug/l

72.3

118.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

396

1.37

1.42

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

423

1.35

1.39

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

238

1.47

1.39

1.1

u/l

1.0

1.1

0.20

106

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.89

1.38

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

424

1.35

1.38

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

1.35

1.38

1.3

1.4

—

(3008898) HLA-B27 [Presence]

125

1511

0.82

1.36

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

425

1.34

1.36

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

222

0.54

1.34

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.91

1.33

1.9

2.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

179

1528

1.18

1.33

2.4

3.0

mmol/l

24.4

24.8

0.76

157

1351

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

673

1.27

1.32

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

106

1.70

1.29

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1508

14382

1.06

1.29

3.5

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

186

1599

1.17

1.28

1.6

1.5

g/l

0.2

0.25

175

1507

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

404

1.34

1.27

1.4

—

(4010399)

399

4404

0.90

1.26

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

162

1379

1.18

1.26

1.9

2.2

g/l

126.4

130.5

1.24

126

1016

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

265

2341

1.14

1.25

4.3

3.7

mmol/l

24.9

0.09

240

2130

(3004451) EKG impression Narrative

311

1.38

1.25

1.3

—

(3014891) Appearance of Pleural fluid

1.82

1.25

1.8

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

116

0.43

1.24

6.8

7.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.86

1.23

1.9

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

2.00

1.23

1.8

1.6

—

(3028433) Virus identified in Specimen by Culture

171

1.52

1.22

1.2

1.1

—

(3003338) MCHC [Mass/volume]

4729

46495

1.05

1.22

24.6

17.8

g/l

331.6

332.2

4.81

4701

46109

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.91

1.22

1.2

1.3

mmol/l

1.3

2.4

—

(3020491) Glucose [Moles/volume] in Blood

426

1.32

1.20

2.2

2.1

mmol/l

7.4

6.8

0.50

283

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

846

1.22

1.19

1.6

g/l

0.6

0.8

2.04

641

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

383

0.68

1.18

1.4

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.31

1.18

2.5

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.31

1.18

5.0

6.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

371

0.67

1.18

1.2

1.4

pmol/l

92.6

151.9

—

107

(3009445) Proteinase 3 Ab [Units/volume] in Serum

294

2629

1.12

1.16

1.5

u/ml

10.5

17.8

0.54

(40759836) Histone Ab [Presence] in Serum by Immunoblot

385

1.33

1.16

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

561

1.27

1.16

3.4

3.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.50

1.15

1.2

1.1

nmol/l

193.4

257.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

272

0.62

1.14

1.3

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1.32

1.14

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1.32

1.14

1.1

—

(3003181) Sodium [Moles/volume] in Urine

124

1044

1.19

1.12

1.3

mmol/l

62.7

64.6

0.18

102

834

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.33

1.12

1.1

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.00

1.12

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.78

1.10

1.3

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

209

1.44

1.10

5.0

1.6

147.3

153.6

0.18

194

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

389

1.31

1.09

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

389

1.31

1.09

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

311

1.35

1.09

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

840

0.80

1.08

1.7

1.5

52.0

60.5

0.91

531

(3020191) Ethanol [Moles/volume] in Serum or Plasma

433

0.71

1.08

1.1

1.4

promille

2.2

1.2

2.15

330

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.31

1.08

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

675

1.23

1.07

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

318

2873

1.11

1.07

2.7

2.6

0.7

0.16

308

2746

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

784

1.21

1.07

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

136

1161

1.17

1.06

1.6

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

408

0.71

1.06

6.4

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

163

1416

1.15

1.03

4.8

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

204

1.42

1.02

2.9

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

716

1.22

1.02

1.2

u/ml

2.6

4.2

0.49

227

(4212803)

1.92

1.02

1.2

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

247

1.38

1.01

1.1

1.2

73.0

50.4

—

(3025315) Body weight

1.88

1.00

5.8

5.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

265

1.36

0.99

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

133

1544

0.86

0.98

1.6

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

2.17

0.98

1.0

1.1

—

(44813793)

343

0.70

0.97

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

140

1.50

0.97

1.6

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

215

1.40

0.97

1.1

ng/l

70.1

494.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

232

1.38

0.97

1.2

—

(3005033) Fetal Nuchal fold Thickness US

354

1.30

0.95

1.3

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

157

1.47

0.95

1.4

1.5

ug/l

0.5

0.4

0.87

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

247

0.65

0.95

18.9

17.4

nmol/l

1737.4

1398.8

0.86

239

(3022313) Gas panel - Capillary blood

299

2714

1.11

0.95

4.0

3.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

741

1.20

0.95

1.6

1.8

u/l

791.0

3569.4

2.21

303

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

443

1.27

0.95

1.6

1.7

—

(3019977) pH of Arterial blood

340

0.70

0.93

1.8

2.3

7.4

—

124

(3047352) Trisomy 18 risk [Likelihood] in Fetus

356

1.29

0.92

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.82

0.92

1.1

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.14

0.91

1.0

—

(21494434) Karyotype in Bone marrow

419

1.27

0.91

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

261

1.34

0.91

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

366

1.29

0.91

1.3

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

320

2924

1.10

0.90

2.7

1.2

0.11

320

2906

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

305

1.31

0.90

2.4

—

(3047181) Lactate [Moles/volume] in Blood

162

1833

0.88

0.86

4.0

5.8

mmol/l

1.4

1.3

0.25

141

1623

(1761868) Lipid panel - Serum or Plasma

1863

18052

1.04

0.86

3.1

3.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

570

0.79

0.85

1.0

1.1

u/ml

0.6

0.7

0.07

221

(21494755) Public health laboratory ask at order entry panel

316

3442

0.91

0.84

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

505

1.23

0.84

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

921

9650

0.95

0.82

1.3

iu/ml

32.7

36.6

0.44

268

2978

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.69

0.82

1.7

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

342

0.73

0.82

1.9

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

1.31

0.81

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

237

0.67

0.81

12.4

12.2

nmol/l

981.5

816.5

0.54

223

(3003888) Timothy IgE Ab [Units/volume] in Serum

587

0.80

1.1

u/ml

2.7

3.2

0.19

268

(3024932) HLA-DR beta [Type]

122

1.48

0.80

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

285

1.30

0.79

1.0

1.1

iu/ml

7.0

11.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

200

0.65

0.79

1.1

1.0

u/ml

0.3

0.8

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

175

0.63

0.78

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

175

0.63

0.78

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

175

0.63

0.78

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

175

0.63

0.78

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

456

1.23

0.78

1.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

1433

1.13

0.77

1.7

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

234

1.33

0.77

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

548

1.21

0.76

1.6

1.7

u/ml

28.5

23.9

0.26

125

(3021901) Oxygen saturation in Capillary blood

125

1095

1.14

0.76

2.2

2.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.70

0.75

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.84

0.73

1.3

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.64

0.73

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

362

3890

0.93

0.73

6.2

6.8

mmol/l

24.8

24.6

0.38

335

3613

(3028300) Cannabinoids [Presence] in Urine

894

0.85

0.72

3.3

1.7

—

(3024471) HLA-A [Type]

125

1.44

0.72

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.80

0.72

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

180

1621

1.11

0.72

1.6

1.5

e6/l

9502.8

13244.3

1.23

117

1160

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

687

0.83

0.71

1.0

1.1

u/ml

1.0

1.3

0.28

264

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

326

1.26

0.71

1.9

1.5

u/l

11.9

6.3

0.52

276

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.92

0.70

11.0

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

126

1.43

0.70

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

890

0.85

0.69

3.3

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

146

0.62

0.69

6.2

6.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

582

5515

1.06

0.69

1.5

1.7

1.5

0.30

494

4728

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

610

5789

1.06

0.68

2.4

3.0

ng/l

237.3

223.6

0.29

546

5303

(1001926) Buprenorphine [Presence] in Urine by Screen method

694

0.83

0.68

3.9

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.68

1.1

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

227

0.70

0.67

1.5

1.3

—

(3018572) Chloride [Moles/volume] in Blood

113

1281

0.88

0.67

4.6

6.5

mmol/l

105.6

104.9

1.19

1149

(3004616) Nuclear Ab [Presence] in Serum

736

0.84

0.67

1.4

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

696

1.17

0.67

3.8

17.4

mmol/l

6.7

7.4

1.33

568

(3019174) dRVVT (LA screen)

1.63

0.66

1.1

1.2

—

(3039000) Anion gap in Blood

113

1280

0.88

0.66

4.6

6.5

mmol/l

11.1

11.3

0.31

1148

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.49

0.66

1.3

1.2

mmol/l

1.2

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

885

0.86

0.66

3.3

1.7

—

(3000012) Reticulocyte production index

330

1.24

0.66

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

355

3798

0.93

0.65

1.2

—

(44806420)

202

0.69

0.65

1.9

2.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.59

0.65

1.0

2.9

—

(3016879) Cocaine [Presence] in Urine

819

0.85

0.65

3.5

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

224

2056

1.09

0.64

1.5

1.6

titre

105.7

318.7

—

102

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

514

1.19

0.64

1.1

1.2

96.6

95.0

0.16

482

(3027944) Amphetamines [Presence] in Urine

871

0.86

0.63

2.9

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

138

1237

1.12

0.63

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

144

1294

1.12

0.63

1.2

—

(3044941) Cell count panel - Synovial fluid

116

1029

1.13

0.62

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

121

1.41

0.62

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.67

0.61

1.2

—

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.60

0.61

1.4

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

140

0.64

0.60

1.3

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.54

0.59

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.53

0.59

1.1

1.2

—

(3034426) Prothrombin time (PT)

166

1.33

0.58

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

141

1274

1.11

0.57

2.4

2.8

kpa

8.0

7.9

0.33

127

1179

(3001019) Free T4 and TSH panel - Serum or Plasma

215

1983

1.09

0.57

1.5

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

132

1.36

0.57

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

504

1.17

0.55

1.8

titre

13168.0

1524.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

634

6073

1.05

0.54

2.2

2.4

ug/l

7.5

7.8

0.11

539

5247

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

204

1.28

0.54

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.53

1.5

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.45

0.53

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

0.66

0.51

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

618

0.86

0.51

3.0

3.1

mg/l

16.6

37.0

2.06

445

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

671

0.86

0.50

1.3

1.2

mmol/l

7.2

7.6

0.44

471

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

315

1.21

0.50

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

343

1.20

0.50

2.2

2.1

ug/min

9.6

193.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.48

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

280

1.22

0.48

3.7

3.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.52

0.48

1.0

1.1

u/l

13.3

15.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

121

1331

0.91

0.48

3.3

3.6

mg/l

31.0

27.2

0.46

877

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.45

0.48

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1570

15346

1.03

0.47

4.2

estimate

0.0

1.94

581

4676

(4062490)

550

1.15

0.47

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

277

0.79

0.46

1.2

1.1

ratio

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

201

2153

0.93

0.44

1.2

u/ml

0.3

0.8

1.57

213

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

386

1.17

0.43

1.5

—

(3002619) Bacteria identified in Specimen by Culture

104

1.35

0.43

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

0.76

0.43

1.7

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

0.76

0.43

1.7

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

912

0.90

0.42

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

965

1.10

0.42

1.2

u/l

94.3

26.8

1.40

832

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

584

0.87

0.41

1.1

—

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

283

0.81

0.41

1.0

1.1

—

(3017704) Immunofixation for Urine

323

1.18

0.41

1.8

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.3

—

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

826

0.89

0.41

1.1

iu/ml

28.1

1239.2

0.91

171

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.40

0.0

4.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

370

1.16

0.40

2.7

2.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.33

0.40

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

132

1.29

0.40

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

160

1718

0.93

0.39

1.7

mg/l

2.7

3.7

1.15

118

1217

(4306422)

702

1.11

0.39

1.3

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.39

0.0

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

335

0.84

0.39

1.5

1.3

nmol/l

1.1

1.3

0.43

252

(3023430) Cat dander IgE Ab [Units/volume] in Serum

410

0.85

0.38

1.0

1.1

u/ml

1.2

3.0

1.21

154

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

115

1.30

0.38

1.9

2.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.38

1.0

—

(3015183) Erythrocyte sedimentation rate

192

0.78

0.37

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.35

0.37

2.8

2.6

57.6

65.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.29

0.36

1.3

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

459

1.13

0.36

1.2

1.3

titre

17.1

68.3

—

(3021788) Differential panel - Synovial fluid

129

1197

1.08

0.35

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

291

1.17

0.35

3.2

4.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2125

21563

0.98

0.35

4.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

0.75

0.34

1.1

1.4

—

(3045424) Erythrocytes [Presence] in Urine

103

948

1.09

0.34

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

236

2487

0.95

0.34

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

499

1.12

0.34

1.6

2.3

u/field

2.4

1.8

0.27

190

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

537

1.12

0.34

1.1

1.3

nmol/l

1.4

0.21

480

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.37

0.34

3.1

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

127

1.26

0.33

1.7

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

1.23

0.32

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

444

0.88

0.32

1.0

1.1

u/ml

0.5

2.4

4.21

168

(3028192) IgG subclass 2 [Mass/volume] in Serum

550

1.11

0.32

1.3

1.4

g/l

2.6

3.0

0.96

385

(3024139) IgG subclass 3 [Mass/volume] in Serum

550

1.11

0.32

1.3

1.4

g/l

0.7

0.4

0.47

387

(3027135) IgG subclass 1 [Mass/volume] in Serum

551

1.11

0.31

1.3

1.4

g/l

7.5

6.8

0.38

384

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

358

0.87

0.31

1.0

1.1

u/ml

0.1

0.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

100

0.70

0.30

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

138

1.23

0.30

1.5

2.5

mmol/l

7.5

8.0

0.23

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

120

1.25

0.30

1.7

1.2

—

(3022621) pH of Urine by Test strip

381

3950

0.96

0.30

2.9

3.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.29

0.30

1.3

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

382

1.13

0.29

1.1

1.0

mg/l

291.0

286.0

0.17

346

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

148

1.22

0.29

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

439

0.89

0.28

1.4

1.2

titre

131.4

168.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

114

1068

1.07

0.27

1.2

u/ml

51.4

41.1

—

116

(3005011) Chlamydia sp Ab [Titer] in Serum

1.23

0.27

1.5

1.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

168

1.19

0.27

1.2

g/l

0.3

0.60

135

(3038071) Oxygen [Partial pressure] in Mixed venous blood

139

0.79

0.26

5.9

7.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

673

1.09

0.26

1.1

1.2

123.0

115.9

1.12

605

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

150

1.20

0.26

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.69

0.26

1.0

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.68

0.26

1.0

1.3

—

95.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.68

0.26

1.6

—

(4211845)

310

1.13

0.25

3.6

3.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

320

0.87

0.25

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

578

1.09

0.25

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

192

0.83

0.25

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

716

0.92

0.25

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.20

0.25

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

967

1.07

0.24

1.2

1.3

miu/ml

228.1

217.3

0.10

424

(3004775) Volume in Urine collected for unspecified duration

551

1.09

0.24

2.7

2.3

658.8

637.9

0.16

386

(3025018) Bordetella pertussis Ab [Titer] in Serum

255

1.14

0.24

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

243

2337

1.04

0.24

1.1

titre

35.0

199.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

725

7098

1.02

0.24

1.4

—

(3000330) Specific gravity of Urine by Test strip

310

3205

0.97

0.23

3.1

3.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

1.5

umol/l

0.6

0.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

125

0.80

0.23

1.7

1.5

ng/l

106.8

107.5

—

125

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

209

1.15

0.22

3.2

2.7

umol/l

27.8

28.5

0.16

155

(4094501)

175

1675

1.05

0.22

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

284

0.88

0.22

1.4

1.3

mmol/l

6.0

6.1

0.24

268

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

326

0.89

0.22

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

378

0.90

0.21

1.3

u/ml

0.2

1.0

1.77

185

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.19

0.21

2.2

1.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

1.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

209

2011

1.04

0.21

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

325

0.89

0.21

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

304

0.89

0.21

2.1

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

104

0.77

0.21

1.0

1.1

—

5.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

167

1743

0.96

0.21

1.8

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.16

0.21

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

162

1692

0.96

0.21

2.6

2.3

ug/min

74.2

115.5

1.30

104

1011

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

230

1.13

0.20

2.8

1.9

ug/l

19.6

171.4

0.68

214

(3024263) Appearance of Synovial fluid

335

1.11

0.20

1.9

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

278

1.12

0.20

1.0

1.1

—

3.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

119

1132

1.05

0.20

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

269

1.12

0.19

1.7

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

127

1.18

0.19

1.3

1.1

—

(3025577) Chromium [Mass/volume] in Blood

481

1.08

0.19

2.1

2.0

ug/l

1.9

2.3

0.53

402

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

103

977

1.06

0.19

1.6

1.9

pmol/l

198.3

197.3

0.04

913

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

175

1819

0.96

0.19

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.13

0.18

1.0

1.2

umol/24h

2.1

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

807

0.94

0.18

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1148

11331

1.02

0.18

1.3

1.2

u/ml

1.5

1.9

0.62

267

2981

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

1.17

0.18

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

847

0.94

0.18

1.4

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

2011

19933

1.01

0.18

3.4

3.2

mmol/l

7.2

7.4

1.01

1661

16576

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

425

1.08

0.18

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

258

0.89

0.17

1.0

—

(3016038) Potassium [Moles/volume] in Urine

397

1.08

0.17

1.1

mmol/l

29.9

34.6

0.91

325

(3010726) Horse dander IgE Ab [Units/volume] in Serum

506

0.93

0.17

1.0

1.1

u/ml

0.1

2.1

—

114

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.74

0.17

8.6

10.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

158

1639

0.96

0.16

1.5

1.6

iu/ml

0.1

2.2

0.66

355

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

340

1.09

0.16

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

183

0.87

0.16

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

277

0.90

0.16

5.9

5.1

u/ml

788.0

819.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

271

2639

1.03

0.16

1.6

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

331

1.09

0.16

7.6

10.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

251

2442

1.03

0.16

1.5

—

(3019060) Gas panel - Arterial blood

416

4076

1.02

0.15

3.7

4.6

—

(4133840)

130

1.15

0.15

1.1

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

748

7372

1.02

0.15

1.3

titre

547.1

523.6

0.12

149

1610

(3039443) Prostate specific Ag panel - Serum or Plasma

104

995

1.05

0.15

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

809

1.05

0.15

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.10

0.15

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

624

0.95

0.14

1.6

1.5

37.1

29.3

0.75

405

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

212

0.90

0.14

1.1

miu/ml

1540.3

1624.1

0.12

212

(3012516) Albumin [Mass/volume] in Urine

1961

19472

1.01

0.13

3.5

3.2

mg/l

469.1

321.8

0.65

1236

12363

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

481

1.06

0.13

1.2

1.3

titre

1352.0

511.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

152

1.12

0.12

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

925

0.96

0.11

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

599

0.95

0.11

1.1

u/ml

2.0

3.4

0.95

242

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

143

1.12

0.11

1.1

1.3

—

(4024509)

592

1.05

0.11

1.4

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

125

0.88

0.10

1.2

1.1

umol/24h

0.9

0.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2045

20558

0.99

0.10

4.3

4.0

mg/mmol

7.4

9.1

1.12

1262

12979

(3032773) Endomysium IgG Ab [Titer] in Serum

433

0.95

0.10

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

535

1.05

0.10

1.1

—

(3044927) Protein electrophoresis panel - Urine

693

1.04

0.09

1.4

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

135

1.11

0.09

1.1

1.2

pmol/l

182.0

274.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.06

0.09

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.06

0.09

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

300

2953

1.02

0.09

1.7

1.8

—

(3011288) Drugs identified in Urine by Screen method

574

0.96

0.09

5.9

2.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

482

0.95

0.09

1.1

—

(4146454)

754

1.03

0.09

2.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

165

0.91

0.08

1.1

1.3

50.4

34.5

—

102

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.05

0.08

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

107

1.12

0.08

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

175

1.09

0.08

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

119

1220

0.97

0.08

1.2

—

15.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

146

1.10

0.08

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

379

0.95

0.08

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.08

1.4

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

234

1.07

0.08

1.5

2.1

umol/l

95.3

139.5

0.79

127

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.08

0.08

1.1

1.6

umol/l

45.1

45.2

—

(3018133) Calcium [Moles/volume] in Urine

1.04

0.08

2.3

1.6

mmol/l

2.6

2.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.03

0.07

1.1

u/ml

75.4

62.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

235

0.94

0.07

1.0

1.1

iu/ml

124.7

210.2

1.64

230

(3004119) Hemoglobin [Mass/volume] in Venous blood

387

3828

1.01

0.07

2.9

3.3

g/l

127.3

130.2

1.66

377

3722

(36660697) Celiac disease serology panel - Serum

408

4123

0.99

0.07

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

206

1.07

0.07

2.4

1.9

ug/l

53.4

50.2

0.18

200

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

163

0.92

0.07

5.7

7.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.88

0.06

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

128

1.09

0.06

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

100

0.90

0.06

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

710

1.03

0.06

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

162

0.93

0.06

1.1

—

(4015189)

188

1.06

0.05

1.7

2.5

—

(40761535) Cells panel - Urine sediment

515

5186

0.99

0.05

3.6

3.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

119

1170

1.02

0.05

1.8

1.6

nmol/l

0.8

0.14

102

964

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

169

1.07

0.05

1.3

1.1

—

(40757373) Influenza virus identified in Isolate

120

1.08

0.04

1.8

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

319

3164

1.01

0.04

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

1.07

0.03

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

633

0.98

0.03

1.3

e6/l

169491.5

178933.1

0.03

436

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

280

0.96

0.03

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

158

0.95

0.02

1.6

1.5

mmol/l

8.0

8.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

339

0.97

0.02

1.5

1.6

umol/l

8.4

7.0

0.22

234

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

1.07

0.02

1.2

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

123

1.06

0.01

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

147

0.95

0.01

1.4

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

153

1520

1.01

0.01

1.2

u/ml

67.9

43.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

143

1421

1.01

0.01

1.2

u/ml

5.0

0.00

229

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

313

1.02

0.01

1.8

2.0

u/field

2.0

0.02

212

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

1168

0.99

0.01

1.2

u/ml

6.8

5.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

190

1892

1.00

0.01

4.4

4.3

mmol/l

3.9

0.30

181

1782

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

1.04

0.00

1.4

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

144

1.04

0.00

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

166

0.96

0.00

1.8

1.5

ug/l

7.5

9.0

1.86

166

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

123

0.98

0.00

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

146

1.03

0.00

1.6

—

(3022689) Creatine [Moles/volume] in Urine

194

0.98

0.00

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

226

1.02

0.00

1.3

1.2

g/l

38.7

39.2

0.05

112

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

994

1.00

0.00

1.3

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

1404

1.00

0.00

1.2

u/ml

2.0

7.1

—

146

(3006653) Thiamine [Moles/volume] in Blood

269

1.00

0.00

1.2

nmol/l

132.9

137.9

0.32

269

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.87

0.00

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.90

0.00

1.1

1.9

umol/l

13.7

17.8

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

152.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.91

0.00

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.92

0.00

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.98

0.00

1.3

nmol/l

7.6

380007.7

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

35.6

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

180

1.00

0.00

1.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.92

0.00

1.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1206.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

3.9

—

18.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.01

0.00

3.0

2.8

u/field

0.4

0.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.94

0.00

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MELANOMA_EXALLC – Malignant melanoma, excluding all cancers (controls excluding all cancers)

GWS hits: 22

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant melanoma, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant melanoma, excluding all cancers (controls excluding all cancers) (C3_MELANOMA_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints